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Abstract

NEURODEVELOPMENTAL DEFECTS ASSOCIATED WITH GESTATIONAL
EXPOSURE TO LOW LEVELS OF DBP IN MICE

By
Francoise Sidime

Advisor: Professor Abdeslem El Idrissi, PhD

The etiology of autism is thought to involve the complex interplay among genetic and
environmental factors. Patterns of inheritance suggest an epigenetic component to the
development of autism. A variety of environmental risk factors are known to induce epigenetic
changes in DNA, affecting many genes including those autism-associated genes (AAG). The
plasticizer dibutyl phthalate (DBP; CAS 84-74-2) is a developmental and reproductive toxin that
causes a broad range of birth defects resulting in neurological impairments.
To date, although the effect of DBP as an endocrine and a reproductive disruptor are established,
there are only few studies that address the effects of low levels of DBP. In addition, there are
limited reports on the neurotoxic effects of this phthalate on the developing and mature brain.
Additional research analyzing the low-dose effects of this endocrine disruptor need to be further
investigated, since it is most un likely for humans to be exposed to high concentrations of DBP.
This study aimed to investigate the neurotoxic effects of gestational exposure to low levels of
DBP in the offspring of mice.
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Our current findings suggest that gestational exposure to low doses of DBP causes genderspecific neurobehavioral abnormalities in the offspring, consistent with those found in humans
on the autism spectrum. These neurobehavioral alterations elicited by DBP were consistent with
altered inhibitory (GABA) function in the brain. We hypothesized that gestational exposure to
DBP altered the maturation of the GABAergic system, which lead to developmental delay
observed. In addition, we used the fragile x mouse model (fmr1 ko) and found that all DBPinduced phenotypes were reproducible and exaggerated in the fmr1 ko. Since fmr1 ko mice have
diminished GABAergic function, show abnormal expression of many genes implicated in the
etiology of autism, and show many of DBP-induced behaviors (e.g heightened anxiety, and
hyperactivity) this further confirmed the strong link between the genetic makeup and the
susceptibility to environmental risk factors. Our data showed that adult male mice at postnatal
day 60 (PND 60) injected with DBP (1 mg/kg BW i.p) showed significant neurobehavioral
alterations characterized by reduced locomotive activity in the open field test. These effects were
observed 15 min post DBP injection, indicating a fast-acting mechanism. These findings
suggested that DBP targeted key proteins regulating neurobehavioral activity and that gestational
exposure may alter the biochemistry of the brain to induce long lasting neurobehavioral deficits.
Thus, in order to determine the effects of DBP on early brain development, we injected pregnant
mice with DBP on gestational day 10 in order to target critical windows of brain development,
mainly neurogenesis (embryonic day 10 (E10) and E20). This critical window precedes dendritic
growth and spinogenesis that spans from E20 and continues to postnatal day 40 (PND 40).
Recent findings in the past decade have introduced the ideology that the brain generates
neurosteroids de novo using steroidogenic key proteins similar to those found in periphery
glands. These neurosteroids are produced in high concentrations early in development to
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promote the protection and development of the central nervous system. DBP interferes with
steroidogenesis by down-regulating the expression of key steroidogenic proteins during
embryogenesis. Interference during this time period can cause developmental delay and
alterations in the organization of the GABAergic system critical for the formation and
connection of neuronal networks. Our findings demonstrated that some of the neurobehavioral
phenotype elicited by a single injection to the adult mice could be reproduced in the offspring of
DBP-injected pregnant mice. The prenatal exposure of DBP in the offspring mice at PND 60
exhibited increase in locomotive activity and anxiety, heightened fear-potentiated freezing
response and a significant decrease in learning as measured by Morris water maze and the
acquisition and retention of a passive avoidance task. In the social interaction paradigm, DBP
offspring exposed mice exhibited a reduction in the number of social interactions when presented
with a stranger mouse compared to non-DBP treated mice. Interestingly, there was a significant
decrease observed in fmr1 ko male mice. Our findings for the passive avoidance learning task
were also male-specific. These neurobehavioral effects elicited by exposure to DBP were
consistent with altered inhibitory function in the brain of these mice. Since all the behavioral
tests results were heightened in males much more than females; we sought to focus our efforts on
understanding the molecular mechanisms underlying the effects of DBP on neurodevelopment in
males.
To elucidate the molecular and neuronal basis mediating DBP-induced neurobehavioral
alterations, we mapped the temporal expression of GABAergic markers (GABA A receptor and
glutamic acid decarboxylase (GAD67)). Since the GABAergic system plays a crucial role early
in development by establishing neuronal formation and networks; we investigated the expression
of two essential co-transporters that aid the system in orchestrating these events - The sodium
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potassium chloride co-transporter (NKCC1) and potassium chloride co-transporter (KCC2).
These pumps are responsible for establishing the chloride electrochemical gradient switch early
in development. The early gradient generates the excitatory actions of GABA and results in the
driving force behind the formation of these neuronal networks. Finally, we analyzed key proteins
in the steroidogenic pathway (steroidogenic acute regulatory protein (StAR) and the
mitochondrial enzyme P450 side chain cleavage (P450scc) in the brain. These proteins are rate
limiting and essential in the synthesis of neurosteroids like progesterone and estradiol. These
critical neurosteroids are essential in the regulation of dendritic growth, spine generation and
synaptogenesis.
Our results showed that gestational exposure of DBP significantly increased mRNA levels of
StAR and P450scc. Additionally, mRNA levels for the β3 subunit of the GABA A receptor were
significantly upregulated in early development (PND 1 and 7). Although embryogenesis marks
the time of increased growth, development and increased peak production of neurosteroids, these
findings are consistent with studies showing that insult to the brain also elevates mRNA levels of
StAR and the activity of P450scc as a neuroprotective mechanism. Later in development at PND
60, the levels of mRNA were significantly decreased. Consistent with this reduction in gene
expression of StAR and P450scc, GAD67 and the GABA A receptor protein expression were also
reduced.
Since the GABAergic system is the major inhibitory system in the CNS and steroid hormones
regulate GABA A receptors, we tested the threshold for seizure induction as an index for the
potency of the GABAergic system. We found that the offspring of DBP-injected mice had a
significant decrease in the threshold of limbic seizures as measured by reduced latency, increased
duration and mortality rate in response to kainic acid injection (15 mg/kg BW). Additionally, in
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vivo electrophysiological recordings from the cortex showed that in utero DBP-injected mice
experienced higher frequency discharge and lower threshold of seizure activity when injected
with low doses of kainic acid (5mg/kg BW) compared to controls. Furthermore, the fmr1 ko,
with intrinsic seizure susceptibility, showed a further reduction in seizure threshold and
increased excitability when exposed to DBP in utero.
Our findings indicated that gestational exposure of DBP induced neurotoxicity in the brain by
disrupting the expression of key proteins in the steroidogenic pathway. Furthermore, disruption
of this pathway early in development may have caused a delay in the developmental maturation
of the GABAergic system. These results may provide supporting evidence in the understanding
of the neurotoxicity of DBP in the developing and mature brain.
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Introduction
Phthalates are liquid plasticizers used in the industrial production of consumer goods to impart
flexibility in plastic products, food packaging materials, cosmetics and children’s toys (Lottrup et
al., 2006; Mylchreest et al., 2000; Petersen et al., 2000). As a result of their wide use, the
potential for human exposure is significantly high especially among individuals using polyvinyl
chloride based devices like drinking bottles and plastic plates. Furthermore, young women of
reproductive age using phthalate based cosmetics products have been reported to have high
levels of phthalates metabolites in their urine (Blount et al., 2000; Kohn et al., 2000; Koch et al
2003; Thompson et al., 2004). According to a study conducted by Thompson et al., (2002), most
human exposure to phthalates occur through contaminated food, dermal exposure through
cosmetics, or by inhalation of air containing these compounds. Since phthalates are widely used,
they are considered ubiquitous low level environmental contaminates.

Phthalates are also categorized as endocrine-disrupting compounds (EDCs); chemicals suspected
of having teratogenic effects that alter the functions of the endocrine and reproductive system by
means of interference with endocrine organs (Gray et al. 2000). EDCs are known to cause fetal
death, malformation and reproductive toxicity in laboratory animals (Shea, 2003; Mylchreest et
al., 2000; Zeng et al. 2013) and humans (Colon et al. 2000, Hu et al. 2003). Although not all
phthalates are toxic; there is speculation that the toxicity of certain groups of phthalates like
Dibutyl phthalate (DBP) is attributed to the extent and branching of the alkyl chains of the
molecule (Gray et al., 2000).

The deleterious effects of DBP affecting the endocrine system in human and animal models is
well documented (Crisp et al., 1998; Gray et al., 1999; Swan et al., 2005; Thompson et al.,
1

2004); however, there is increasing concern over the potential impact of DBP on
neurodevelopment (Li et al., 2013; Li et al., 2014). Models of how DBP can impact specific
regions of the brain have begun to develop. A study by Kim and colleagues (2009) reported the
association of DBP metabolites with neuropsychological impairment in children aged 8-11 years
(Kim et al. 2009). Progress has been made in the last two years regarding the mechanisms that
could underline the neurotoxicity effect of DBP in utero. Prenatal exposure of a high dose of
DBP (500mg/kg BW) induces hippocampal structural and neuronal loss in the developing rat
brain. In addition, the effect of DBP on the impairment of spatial learning and memory are also
documented (Li et al., 2013). These findings later initiated a study that suggested that DBP may
induce neurotoxic effects in the immature brain by affecting the steroid hormone estradiol and its
receptors (Li et al., 2014).

While peripheral organ glands including the testes, ovaries and adrenal gland synthesize steroids,
neurosteroids are synthesized de novo by the brain (Akwa et al., 1991, Baulieu, 1990; Baulieu,
1991). An interesting revelation in the revolution of endocrine steroids was the discovery that the
brain expressed the steroidogenic acute regulatory protein (StAR) and the mitochondrial enzyme
P450 side chain cleavage (P450scc) (Figure 1). The biosynthesis of neurosteroids estrogen and
pregnanolone proceeds through the transfer of cholesterol from the outer to the inner
mitochondrial membrane through the steroidogenic acute regulatory protein (StAR). The
cholesterol side chain is cleaved by cytochrome P450 side chain cleavage (P450scc), a rate
limiting mitochondrial enzyme originally found in peripheral steroidogenic glands and recently
reported in the brain (Baulieu, 1990). The cleavage results in cholesterol conversion to
pregnanolone or estrogen, depending on the activation of other enzymes responsible for their
synthesis (Baulieu, 1990; Baulieu, 1991).
2
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Figure 1: Biosynthesis/metabolism of steroids (Thompson et al., 2004).
Cholesterol is shuttled through the mitochondria by the steroidogenic acute regulatory protein
(StAR). The enzyme P450scc cleaves cholesterol to pregnenolone. Pregnenolone undergoes a
series of enzymatic reactions depending on the enzyme present (Thompson et al., 2004).

A study by King and colleagues (2011) shows that the brain not only synthesizes neurosteroids,
but does so with peak elevations decreasing early in development. This spike in neurosteroid
synthesis coincides with increases in neuronal growth, dendritic spine formation and
development (Sierra et al. 2003) including peak expression of StAR and P450scc mRNA levels
(King et al., 2011). Neurosteroids regulate the physiology of developing neurons while providing
neuro protection (McCarthy 2008, King et al., 2011). Besides the neuroprotective roles of steroid
hormones, neurosteroids exert genomic and nongenomic effects such as increasing protein
synthesis which subsequently leads to synaptogenesis; and allosterically modulating GABAA
receptors (Figure 2).

3

Neurosteroids exert their genomic affect by acting as transcription factors, and in the brain are
involved in dendritic growth and spine generation (Rupprecht, 1997; Rupprecht and Holsboer,
1999, King et al., 2011). As part of their nongenomic effects, neurosteroids allosterically
modulate GABA A receptors (Baulieu, 1991). An increase in the allosteric modulation of these
receptors by the neurosteroid pregnanolone leads to increased chloride influx and thus; extended
GABA-mediated inhibition. Once considered the main source of inhibition, we now know it to
be the primary source of excitation early in development; through GABA induced depolarizing
effect and subsequent calcium influx through voltage sensitive calcium channels (VSCCs). The
excitatory effect of GABA early in development is extremely important as it is linked to trophic
actions that function as guidance cues and promotes maturation of synapses (McCarthy 2008).
These cues navigate the immature neurons to their destined location where they begin to signal
giant depolarizing potentials (GDPs) resulting in higher influx of calcium. Moreover, GABA’s
excitatory effect on post synaptic cells allow the synchronous activity of GDPs that are pivotal
for developing neuronal networks (Ben-Arie, 2002).

Figure 2: The Genomic and non-genomic effect of neurosteroids.
4

Neurosteroids alter neuronal excitability at the cell membrane by interacting with the GABAA
receptor as part of their non-genomic affect. As part of their genomic effect; steroid hormones
diffuse across the cells membrane, bind to intracellular receptors, and enter the nucleus, and
control gene transcription and, subsequently, protein synthesis. Neurosteroids regulate dendritic
growth and spine generation (Shulman et al., 2005).

Steroid hormones play a significant role in the establishment of this process early in
development. The steroid estradiol augments the excitatory actions of the depolarizing GABA by
increasing the amount of calcium influx, increasing the magnitude of neurons responding to
GABA and extending the developmental period of depolarizing GABA. The vital role of
estradiol orchestrating the excitatory actions of GABA lies in its action of increasing the amount
and activity of the chloride transporter NKCC1. As a result, the intracellular chloride levels and
GABA’s depolarizing action are maintained (McCarthy 2008). Interference with the NKCC1
causes a development shift where chloride influx via ionotropic GABA receptors results in
hyperpolarization, as seen in a study conducted on cultured rat dorsal root ganglions (DRG)
(Chabwine et al., 2015).
The sodium/potassium/chloride cotransporter (NKCC1) and potassium/chloride transporter
(KCC2) control the developmental shift in GABA from excitatory to inhibitory in immature
neurons (Hasbargen, et al., 2010). These neurons possess a very high intracellular chloride
concentration made possible by the over expression of NKCC1 that shuttles chloride into the
cell. Upon activation of the GABA A receptors (GABA A Rs), there is an efflux of chloride, which
depolarizes the membrane. This depolarization subsequently activates voltage sensitive calcium
channels (VSCCs) that promotes calcium influx and triggers a series of events that includes gene
expression (Ben-Ari, 2002). During development, targets genes that expressed are relevant for
reversing the electrochemical gradient of chloride. Most importantly, there is an increase in the
5

expression of the KCC2 that pumps chloride out of the cell and a reduction in NKCC1 (Gamba,
2005). As a result, there is net loss of chloride that leads to membrane hyperpolarizing when
GABA A Rs are activated. This switch from excitatory to inhibitory occurs in the first week of
birth in the rodent brain (Figure 3).

Figure 3: The GABA switch: GABA switches from depolarizing to hyperpolarizing during
development (Figure from Ben-Arie, 2007)

GABAARs are the major inhibitory ionotropic receptors, but during early development
activation of GABAARs exert excitatory effects that set the major synchrony of giant
depolarizing potentials (GDPs) responsible for forming neuronal networks. A) In early
developmental stages, intracellular chloride concentrations are high and as a result, an chloride
efflux via the GABAARs causes a depolarizing effect upon receptors activation (left). Later in
6

development, the intracellular chloride concentrations are reduced, resulting in the chloride
influx (right), resulting in membrane hyperpolarization. B) The excitatory to inhibitory switch of
GABAAR-mediated responses results from the decrease in the expression of NKCC1 cotransporter and increase in the KCC2 co-transporter. The increased expression of KCC2 moves
chloride from the GABAergic neurons, thus maintaining a low intracellular chloride
concentration, which contributes to GABAergic inhibitory effects.

The use of the Fragile X mouse model allowed us to study DBP exposures and genetic
predispositions affecting the behavior of the mice that were tested. In addition to the down
regulated GABA A receptors in FMR1-ko mice (Bakker et al. 1994; El Idrissi et al., 2005) the
time-course of excitatory to inhibitory switch of GABA function during early development is
shifted (Yan X, Dissertation 2013- Unpublished data). This shift caused developmental delay
that we believe could have led to aberrant behavior due to improper network connectivity and
aberrant neuronal formation.

Based on these evidences, we hypothesized that administering DBP in utero would trigger a
cascade of events that would interfere with key proteins needed for establishing neuronal
networks and formation in the developing brain. As a result, we believed that this interference
would affect the maturation of the GABAergic system. Because DBP interferes with
steroidogenesis (Thompson et al., 2004, Li et al., 2013; Li et al., 2014), we believed that the
down-regulation of the key proteins like StAR and P450scc in this pathway and the interference
with the neurosteroids estradiol and pregnanolone will offset the developmental trajectory in
these brain exposed to DBP in utero.

In this present study, we determined the neurodevelopmental effects associated with gestational
exposure to low levels of DBP. Our findings provided evidence that DBP induced
neurobehavioral alterations, altered the expression of key proteins like the GABAARs and
7

GAD67 in the GABAergic system and StAR and P450scc in steroidogenic pathway and finally,
it

contributed

to

the

developmental

delay
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that

is

seen

in

cases

of

Autism.

MATERIALS AND METHODS
Animals
For these studies, we used the fmr1 knockout (KO) as a model for phenotypes similar to those
expressed in ASD and the FVB/NJ strain as the genetic match for wild-type (WT). All animals
were reared in a controlled environment with 12:12 LD cycle and food and water available ad
libitum. Use of animals were approved by the College of Staten Island’s Institutional Animal
Care and Use Committee (IACUC) according to NIH guidelines. For both WT and KO strains,
treatment with 1 mg/kg DBP by i.p. injection was done for acute studies. For developmental
studies, pregnant dams were injected using 1 mg/kg of DBP subcutaneously inorder to avoid the
puncturing of the placenta. The subcutaneous delivery of DBP would circulate through the
pregnant dam’s blood eventually crossing the placenta and subsequently targeting the offspring
brain. For euthanasia, animals were injected with 125 mg/kg Nembutal i.p.

High-performance liquid chromatography (HPLC)
In order to detect whether DBP was present in the brains of the pups that were exposed to DBP
through their injected pregnant mothers, an HPLC test on the brains were conducted. Whole
brains from euthanized pregnant dams and their pups (+/-) DBP were homogenized in hexane
using 100mg of brain tissue to 10ml of hexane. The samples were lyophilized for 24 hours to
remove any traces of hexane. The lyophilized tissues were then dissolved in acetonitrile and
injected into the HPLC machine. In order to detect the peak of DBP as a standard to compare the
findings in the tissues, we injected DBP into the machine and recorded the peak spike. A
standard curve was also generated inorder to aid in the quantification of the tissues containing
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DBP. The peaks generated in all the tissues (+/-) DBP were quantified and recorded by
measuring the area under the peak and calculating the concentration found in the brain.

Western Blotting
Brains from euthanize animals were removed and dissected into cortex, hippocampus,
cerebellum, brainstem and diencephalon and frozen on dry ice within 3 min of the sacrifice.
Total soluble and membrane-bound proteins were extracted from each region (Benke et al.,
1999). Protein concentrations of the extracts were determined using a BCA protein assay kit
(Sigma Aldrich) and a microplate spectrophotometer (Spectra MAX 340PC – Molecular
Devices, CA, USA). After separation by sodium dodecyl sulfate-polyacrylamide gel
electrophoresis (SDS-PAGE), the separated proteins were electrophoretically transferred to a
PVDF membrane (Fisher Scientific, USA) in Tris-buffered saline with 20% methanol. The
membranes were probed with antibodies directed against P450 (1:10,000 dilution – EMD,
Millipore, USA), anti-StAR (1:500 dilution – Abcam, USA), GABA A R β2/3 (1:100 dilution –
Chemicon International, USA), GABA A R γ C-20 (1:1,000 dilution – Santa Cruz Biotechnology,
USA), GAD67 (1:5,000 dilution - EMD, Millipore, USA), or β actin (1:10,000 – dilution, Sigma,
USA) and followed by a secondary antibody incubation using HRP conjugated goat anti-mouse
or goat anti -rabbit IgG (1:1,000 dilution - Santa Cruz Biotechnology, USA). An HRP enhanced
chemiluminescence (ECL) detection kit (Pierce, USA) was used to detect immunoreactive
proteins. A densometer was used to measure the intensity of the protein bands. The relative
density of the protein bands were calculated and normalized to the density of β-actin using
Image J (NIH, USA).
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Immunohistochemical analysis
PND 60 male mice (WT, WT-DBP, KO, and KO-DBP) were transcardially exsanguinated using
phosphate buffer saline followed by 4% paraformaldehyde (PFA) at 37oC and brains were
removed and post-fixed in 4% PFA for 24 hours at a temperature that I should report here. Brains
were cryoprotected in 30% sucrose, embedded in optimum cutting temperature compound (OCT
– ProScitech, USA) and cyrosectioned at 30 µm. Free-floating sections were permeabilized and
blocked with 2% nonfat dry milk (NFDM) in phosphate-buffered saline (PBS) containing 0.02%
Triton X-100 and 10% normal goat serum (NGS) with continuous agitation for 1 hour. Samples
were incubated overnight at 4ºC in primary antibodies: rabbit anti-P450 (1:8,000 dilution –
EMD, Millipore, USA), rabbit anti-StAR (1:500 dilution – Abcam, USA), rabbit anti-GABA A R
β2/3 (1:500 dilution – Chemicon International, USA), or rabbit anti-VSCC (1:500 dilution –
Chemicon International, USA). Following immunolabeling, samples were washed in PBS and
incubated with Cy 3-conjugated goat anti-mouse (Jackson Immuno-Research laboratories, USA)
or Cy 5-conjugated goat anti-rabbit IgG (Jackson Immuno-Research laboratories, USA)
secondary antibodies for one hour at 37ºC. After washing with PBS, floating sections were
mounted on slides and counterstained with Prolong Gold antifade containing DAPI (Invitrogen,
USA) and cover slipped. The expression and distribution of the proteins were visualized
analyzed using the SP2 AOBS confocal microscope (Leica, USA). For all image acquisitions, the
gain and offset were constant to determine the efficacy of treatments.

RNA isolation and cDNA synthesis
Total RNA was extracted from frozen brain tissue using TRIZOL ® (Invitrogen, USA) and
cleaned to eliminate any potential genomic DNA contamination using Qiagen RNeasy mini kit
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(Valencia, CA) according to the manufacturer’s instruction. OD readings using the Nanodrop
1000 Spectrophotometer (Thermo Scientific, USA) at 260 nm and 280 nm were conducted to
determine the RNA purity and concentration. Reverse transcription was conducted using the
USB First Strand cDNA synthesis kit (Affymetrix, USA) in a reaction mixture that contained
10X transcription buffer, ribonuclease (RNase) inhibitor, 10 mM deoxynucleotides (dNTPs), and
Moloney murine leukemia virus reverse transcriptase (M-MLV RT). Total RNA (1 µg) was
reverse transcribed for 60 minutes at 44 ºC; transcription was terminated by increasing the
temperature to 92ºC for 10 minutes and finally at 4 ºC. A volume of 1 µl of cDNA was used for
real-time quantitative PCR.

Real-time quantitative RT-PCR
cDNA was mixed in a 12.5 µl reaction mix containing SYBR® Green Master Mix (Applied
Biosystem, USA) and 0.5 µl of 10 nM primer (Table 1). In order to activate SYBR® Green
Master Mix that contains Hotstart DNA Taq polymerase, a ten minute heat activation step at 95
ºC was conducted. Real-time quantitative RT-PCR was performed using a thermal cycler
(Biorad, USA) employing 40 cycles of denaturation for 15 seconds and 1 minute of annealing at
60 ºC. Samples were run in triplicate and the mean C t values were quantified to determine
relative expression. The data were normalized to glyceraldehyde 3-phosphate dehydrogenase
(GAPDH).

Primers employed in RT-qPCR (Integrated DNA Technologies)
Gene ID: StAR - Gene Name: Stard3nl - NM_024270
Primer 1: 5'-TTC GAT TCA AAG TGC TGA TAC TTG-3'
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Primer 2: 5'-GCT AAT AGA AAG GCA CTG GTC A-3'

Gene ID: P450scc - Gene Name: Cyp11b1 - NM_001033229
Primer 1: 5'-CAG GCT AAC TCA ATG GAA CTC A-3'
Primer 2: 5'-GCC AGC TCA AAG AAA GTC AT-3'

Gene ID: GABAARB3 - Gene Name: Gabrb3 - NM_001038701
Primer 1: 5'-GCT CCC ACA GTT CTC CAT TG-3'
Primer 2: 5'-ACC CGA TAT TTC TCT TCA ACC G-3'

Gene ID: GAD67 - Gene Name: GAD1 - NM_008077 (1)
Gene ID: VSCC - Gene Name: Clcn3 - NM_173876
Primer 1: 5'-CTT GCC TAC TAT CAC CAC GAC-3'
Primer 2: 5'-ACA ATA ACC ACC AGA GAC ACA G-3'

Gene ID: NKCC1 - Gene Name: Slc12a2 - NM_009194
Primer 1: 5'-CAG ATC CTC AGT CAG CCA TAC-3'
Primer 2: 5'-GGT ATC ATT AAC ATT GCC AGT GG-3'

Gene ID: KCC2 - Gene Name: Slc12a5 - NM_020333
Primer 1: 5'-CCA CCT CTG CTG TCT ACA TC-3'
Primer 2: 5'-AGC CTA TGA CGA TGA CCC A-3'

Gene ID: KCC2 - Gene Name: Slc12a5 - NM_020333
Primer 1: 5'-CCA CCT CTG CTG TCT ACA TC-3'
Primer 2: 5'-AGC CTA TGA CGA TGA CCC A-3'

Gene ID: GADPH - Gene Name: Slc12a5 - NM_008084

SEM analysis of Testes/Leydig Cells
PND 60 male mice (WT, WT-DBP, KO, and KO-DBP) were transcardially perfused using
Karnovsky’s fixative (2.5% glutaraldehyde, 4% paraformaldehyde in PBS) and their testes were
removed, cut in half and post-fixed in Karnovsky’s fixative for 24 hours at room temperature.
Post-fixation, the testes were washed three times with 0.1M PBS for 10 minutes each followed
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by a 10 minute wash using distilled water. The mice testes were then subjected to a series of
dehydration steps at room temperature using a graded ethanol series. The series began at 70%
for 1 hour, 85% for 10 minutes, 95% for 10 minutes and finally 100% twice for 20 minutes each.
The tissues were dried at the critical point of CO 2 using a critical point dryer (Tousimis, USA)
and placed on a metal mounting stub. The testes were coated with 10 nm gold palladium using
the EMS 150R S coater (Electron Microscopy Sciences, Hadfield PA) at a rate of 1nm/minute.
The samples were analyzed using the AMRAY 1910 field emission scanning electron
microscope with an acceleration potential of 5 keV.

Behavioral Analyses
Morris Water Maze:
Two-month old mice were housed individually in an adjacent room in order to acclimate them
for 15 minutes prior to conducting the Morris water maze (MWM) experiment. This behavioral
test measures spatial learning and memory. The MWM protocol used was adapted from the
protocol of Dobkin et al., 2000. A platform measuring 11x11x39 cm was placed in the southwest
quadrant (SW) 30cm from the wall and 2cm below the water level. The maze was filled with
water at 25°C and colored using nontoxic white paint. This “milky” appearance caused a hidden
effect of the platform. A total of 20 trials consisting of 5 trials per day were conducted for 4
days. In addition, a 6th trial was added on the 4th day that consisted of a 60 second probe trial at
the end of the training session where the platform was eliminated. Spatial cues were placed in
each quadrant in order to help the mice navigate the maze and aid in spatial memory. Mice were
allowed to swim freely and were scored based on time spent in a particular quadrant/latency to
find the hidden platform. Recording of the trials were conducted by a vertically mounted video
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camera above the MWM. These training trials were set up to allow the mice to acquire spatial
memory and locating the hidden platform. A month later, the animals were subjected to the
same testing paradigm as described in the 4th trial to retest spatial memory retention for two days.
Day 2 tested spatial memory by removing the hidden platform from the SW quadrant and placing
it 180o to the northeast (NE) quadrant.

Passive avoidance test:
The passive avoidance (PA) fear-aggravated test to measure long-term memory was adapted
from El Idrissi et al., 2000. The PA apparatus was comprised of a light and dark compartment
separated by a guillotine-type door operated by a computer. The dark compartment delivered an
electric shock of 0.5 mA for 2 sec upon closing of the guillotine door. The latency of the animal
to move from the light to dark compartment was sensed by 8 infrared beams on each side which
was controlled by the computer. The computer measured locomotor activity by recording the
number of breaks of the infrared beams and the data were transduced online during testing to
MED-PC-IV® software. Mice were housed individually before the experiment in an adjacent
room 15 minutes prior to the experiment in order acclimate them. Mice were individually placed
in the light compartment with the guillotine door availably open to allow access to the dark
compartment where the shock was administered. Latency to cross over to the dark compartment
was recorded and the trial would end at 180 sec if the animal failed to cross over. The trial also
ended when the animal crossed into the dark compartment and received the shock. The apparatus
was cleaned with 70% ethanol between animals to remove any traces of odor.
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Open-field apparatus:
The open-field test for anxiety and hyperactivity employed a rectangular arena that measured
80x60x15cm subdivided into an outer, middle and inner zone and was adapted from El Idrissi, et
al., 2008. Mice were placed in the center zone to begin recording. The animals were recorded for
a period of 10 minutes by a video camera mounted 1.5m above the arena. Mice were housed
individually before the experiment in an adjacent room 15 minutes prior to the experiment in
order acclimate them. Once the 10 minute recording was complete, mice were returned to their
home cage. The apparatus was cleaned with 70% ethanol between animals to remove any traces
of odor.

Elevated-plus maze apparatus:
The elevated plus maze (EPM) adapted from El Idrissi, et al., 2009 protocol was designed to test
anxiety-like behavior and set up with two open arms measuring arms (30 × 5 cm) and two closed
arms (30 × 5 × 15 cm) connected in a plus sign by a central platform measuring (5 × 5 cm). The
EPM was raised 60cm above ground level with a 100W white fluorescent light 1 meter above the
maze. Mice were housed individually before the experiment in an adjacent room 15 minutes
prior to the experiment in order acclimate them. Mice were placed in the center platform facing
an open arm and their behavior was recorded for 10 min by a video camera mounted 1.5 m
vertically above the maze. Once the 10 min recording was complete, mice were returned to their
home cage. The apparatus was cleaned with 70% ethanol between animals to remove any traces
of odor.
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Context fear and auditory cued conditioning:
The 3-day context conditioning and auditory cued fear conditioning experiment was adapted
from Wehner and Radcliffe (2004). Mice were housed individually in an adjacent room 15
minutes prior to the experiment in order to acclimate them. The experimental paradigm
consisted of 3 days: Day 1: Acquisition phase of 120s acclimation that was followed by a 30s
tone stimulus. A tone was presented for 10 seconds followed by light illumination for 10
seconds. 2 seconds prior to the end of the tome presentation, a 0.5mA foot shock lasting 5s was
administered. The mice’s latency to break the 3 infrared beams was measured every 10 seconds
for 120 seconds prior and after the stimuli had been presented. Four trials separated by 70s intertrial-interval (ITI) constituted as the learning acquisition phase. Day 2: Retention phase
followed the same testing paradigm as Day 1, however only one trail was conducted and the foot
shock was eliminated. Additionally, latency was measured every 10s for 300 seconds. Day 3:
Altered context phase accessed auditory cued learning by the altered contextual test
environment. Auditory cued learning was assessed by the separation of the contextual
environment from the acquisition phase. Fear was accessed by analyzing the data generated
between the conditioned context and the altered context with/without the conditioned tone. The
altered context consisted of a smooth black rubber mat covering the floor grids. The test chamber
was divided using a black Plexiglas insert that generated two triangular compartments. A petri
dish with vanilla essence was placed in the opposite triangular compartment and served as an
olfactory cue to increase exploratory behavior. The apparatus was cleaned with 70% ethanol
between animals to remove any traces of odor. Post testing, mice were returned to their
respective cages.

17

Kainic acid-induced seizures:
Mice were subjected to kainic acid-induced seizures as previously reported by El Idrissi et al.,
2003; El Idrissi and L’Amoreaux, 2008. Mice were subjected to the experiment after being
housed individually in an adjacent room 15 minutes prior to the experiment in order to acclimate
them. Mice from the different treatment groups were administered with kainic acid (15mg/kg,
i.p) and placed in clear Plexiglas chamber. The mice were recorded for a period of 4 hours and
seizure severity was quantified by two independent observers who were unaware of the
treatment. The independent observers recorded stereotypical behaviors like motionless stare,
rearing and falling, clonic convulsions, tonic-clonic seizures (status epilepticus) and death. The
beginning of these behaviors from the time of injection was recorded as latency. Additionally,
the duration of the convulsions were measured as seizure severity.

Three Chambered Social Interaction Test
The social interaction apparatus was composed of one black compartment adjacent to two clear
boxes that had openings on the side and lid covers on the top. This setup was placed on a level
counter top. The openings between the black box and the middle clear box allowed the subject to
roam freely between both compartments. The holes were aligned perfectly to allow accessibility.
The clear boxes had smaller openings so that the mice were prevented from cross over. A black
wooden board was placed behind the three chambered social interaction apparatus to increase
contrast. The recording room was dimly lit at 6 lux and a video recording camera was placed on
a tripod across from the apparatus. The mice were tested individually and the apparatus was
cleaned with 70% ethanol in between trials. Each mouse was subjected to two experimental
trials. The test mouse was placed in the middle clear box and its activity was recorded for 10
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minutes. The second trial consisted of a stranger mouse placed in the side clear box, while the
test mouse remained in the middle clear box. The second trial was recorded for 10 minutes.

Cortical Recording
In vivo recordings from the cortex were conducted to measure the threshold for seizure
inductions. Kainic acid (KA) (5 mg/kg BW), an agonist of kainate receptors, a subclass of
ionotropic glutamate receptors responsible for fast synaptic excitatory currents, was injected into
the cortex to induce ictal activity in stereotaxically fixed animals. The dose of KA used was
subthreshold for seizure induction; however, this dose was sufficient to induce electrical
discharge from cortical structures that sub-served this type of seizures. Following the injections,
we recorded the latency and amplitude of the ictal activity, which was a measure of neuronal
excitability and seizure susceptibility.

Statistical Analysis
Statistical analysis was performed using Statistica V 6.1 (Statsoft, Inc., USA). Data were
analyzed using factorial ANOVA and expressed as means ± standard deviation (SD). Post –hoc
analyses were conducted using Tukey-HSD for unequal n. Significance was set at a confidence
of 95% and results were statistically significant if p < 0.05.
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RESULTS

THE EFFECTS OF ACUTE EXPOSURE OF DBP ON NEUROBEHAVIOR
Low levels of DBP affect the neurobehavior of 2 month aged mice
We used an acute and chronic model of exposure to low doses of DBP to characterize the effects
of DBP on neuronal function and brain development. Acute exposure of adult male mice resulted
in significant neurobehavioral alterations characterized by decreased locomotor activity, as
measured by the OF test. Latency to changes were 15 min post DBP injection, indicating a fast
acting mechanism (Figure 4A, B). Furthermore, these effects were gender-specific, as males
were affected more acutely than females. The neurobehavioral effects elicited by exposure to
DBP were consistent with altered inhibitory function in the brain of these mice; since the
GABAergic system is the major inhibitory system in the CNS and is critically involved in these
behaviors. However, the exact mechanism by which DBP altered neurobehavior remains to be
elucidated. Possibly, DBP mediated its central effects through direct interaction with
neurotransmitter receptors or indirectly through interaction with an allosteric modulator of these
receptors; potentially with a steroid hormone.

When comparing the effects of DBP on locomotor activities in both sexes of the WT and KO
mice were equally affected by DBP (Figure 4 A, B) as measured by the total distance traveled
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(TDT). The OF data reported an increase in anxiety that was observed in both genders (Data not
shown). DBP treatment did not appear to alter the fear response in males (4 C) whether in the

WT or KO; in females, only the DBP-treated WT exhibited a fear response (4 D)

Figure 4a: Acute exposure of 1mg/Kg BW of DBP induces hypo-activity specific effects 15
minutes post administration in PND 60 mice in the open field test.
To determine if acute injection had an effect on neurobehavior, we injected mice with DBP (1
mg/kg i.p) and measured locomotor activity 15 min post injection. (A, B)) A single injection of
DBP significantly reduced the total distance travelled in the PND 60 WT and KO male and
female mice (A, B). DBP effect was more pronounced in KO males than females whereas in the
WT group males and females were equally affected (A, B).
Acute exposure to DBP increased the total number of immobile episodes in both male and
female WT and KO mice (C, D). Similar to the distance traveled, DBP effect was more
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pronounced in KO males than females whereas in the WT group males and females were equally
affected (C, D).
Statistical values are representative of an ANOVA with Tukey’s HSD post hoc test alpha level
0.05% (p < 0.05*, p < 0.01**, and p < 0.001***).

(E)

(F)

Figure 4b: Acute exposure to DBP (1mg/Kg) induces anxiety-like behavior 15 minutes post
injection in PND 60 mice. In order to further characterize the acute effect of DBP on
neurobehavior we measured the total time immobile; the number of line crossings and the time
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spent in various zones (A-F). We found consistently in all the variables measured that DBP
effect was more pronounced in KO males than females whereas in the WT group males and
females were equally affected (A-F). Additionally we found that DBP had an anxiogenic effect
as evidenced by the increased time spent in the outer zone (E, F). Data represent mean ± SEM
and is obtained from at least 10 animals per group.
Statistical values are representative of an ANOVA with Tukey’s HSD post hoc test alpha level
0.05% (*** = WT-DBP; p < 0.001***)
Thus, in subsequent experiments, we tested the effects of DBP on early brain development by
injecting pregnant mice with DBP (1 µg/kg s.c) on gestational day 10 and assessed the
neurobehavioral effects in the offspring when they reached 2 months of age. Our lab has shown
that the expression of GABAAR β3 subunit, GAD and VSCC are critically important in
regulating behavior (El Idrissi et al., 2005, Xin Yan – Unpublished data). The GABAAR β3
subunit required for receptor function is significantly reduced in the cortex and hippocampus of
KO mice. Concurrently, the expression of GAD is increased in the regions where the GABAAR
β3 subunit is reduced. A change in the expression of GABA A or GAD mice can alter the
behavior of mice, as which occurs in the KO mice. Neurosteroids increase the efficacy of
GABAARs; neurosteroids such as pregnanolone are allosteric modulators of GABAAR activities
and subsequently result increase chloride conductance (Baulieu and Robel 1990). Thus, a goal of
this study was to determine the effects of the endocrine-like molecule DBP on gene expression,
endocrine alterations and GABAergic maturation in the developing mouse brain, and examine
how the effects of DBP might be exaggerated in a mouse model with genetically-induced
GABAergic dysfunction. We proposed to study the long-term effects of fetal DBP exposure
using a multilevel approach encompassing epigenetic modifications to maturation of neuronal
circuits, which we think is critically relevant to understanding the involvement of the risk factor
DBP and the genetic predisposition, in the etiology of autism.
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DBP CONCENTRATIONS FOUND IN INJECTED PREGNANT DAMS AND THEIR
OFF SPRING
In order to confirm that gestational exposure to low levels of DBP targets the brain of offspring
mice, a HPLC study was conducted on both the injected pregnant dam and offspring’s brain
tissue. The subcutaneous delivery of a single dose of (1 mg/kg of DBP in PBS) at gestational day
10 to the pregnant dam revealed that DBP was indeed found in the brain of both the mother and
offspring. Both were sacrificed on PND 1 when the pups were born and their tissues were
examined. In order to determine the peak of DBP, the phthalate was injected into the HPLC
machine where a reading of 24.592 was reported (Figure 5A). This peak was used to as a
reference point to confirm the peaks that would be observed in the pregnant dam and their
offspring’s brain. A concentration of 0.05ug/g was found in the offspring’s’ brain (Figure 5B),
compared to the tenfold increase of 0.5ug/g found in the pregnant dam’s brain (Figure. 5C).
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Figure 5: HPLC readings of DBP found in pregnant dam and offspring (A) Control sample to
identify peak of DBP at 24.592 on HPLC reading (B) Pregnant dam area under peak calculated
to 0.5ug/g of DBP found in brain (C) Offspring of pregnant dam injected with DBP area under
peak calculated to 0.05ug/g of DBP found in brain

Gestational exposure of low levels of DBP disrupt key proteins in steroidogenesis

In order to induce prenatal exposure of DBP, 2-month-old pregnant mice (WT + KO) were
injected subcutaneously with a single dose of DBP (1 mg/kg DBP in PBS) at gestational day 10.
Pregnant age-matched mice (WT + KO) were injected with PBS and served as controls for each
strain. Acute exposure to DBP exaggerating the autism endophenotype in KO mice suggested
that DBP targeted neuronal substrates, mediating such a phenotype. Since the GABA A Rs are
critical in mediating normal behavior, dysregulation in GABA-mediated inhibition may be a
critical link to symptoms exhibited in the fragile X syndrome; these include seizures, anxiety and
autistic-like behaviors (D'Hulst et al., 2006; El Idrissi et al., 2005; Kooy, 2003; Selby et al.,
2007). During early development, the activation of GABAARs is critically important in the
development of immature neuronal networks. Expression of P450scc and StAR is critically
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important for neurosteroid synthesis that may regulate gene transcription (McCarthy, 2008). To
analyze the developmental disruption potentially affected by DBP, we investigated the effects of
DBP on P450scc and StAR transcription and translation. We hypothesized that DBP interfered
with the biosynthesis of the neurosteroids like estrogen and pregnanolone by reducing the
expression of P450scc and StAR. As a result, DBP induced a developmental delay in the
maturation of the GABAergic system through inhibition of neuroactive steroid synthesis.

In order to confirm that DBP injected into the pregnant dams’ targeted the brains of their
offspring, we conducted a HPLC analysis. We found that a single dose of DBP (1 mg/kg DBP in
PBS) injected to the mother subcutaneously resulted in 0.05ug/g of DBP found in the pup’s brain
(Figure 5C). Interestingly, the pregnant dam had ten folds the concentration of DBP (0.5ug/g) in
its brain compared to the offspring (Figure 5B).
We measured the mRNA levels of P450scc in the cortex and hippocampus region at PND 1,
PND 7 and PND 60 in offspring mice exposed to DBP in utero. In the WT mice, DBP had no
significant effect on P450scc transcription (Figure 6 A-C). For the KO mice, DBP caused a
significant increase in P450scc transcription on PND 7; by PND 60 transcription of P450scc had
ceased in the KO mice (Figure 6C). On PND 7, a critical day in brain development, the KO had
a significantly lower amount of P450scc mRNA than the WT (p < 0.05; Figure 6B).
In the hippocampus, DBP-treatment resulted in higher P450scc mRNA levels at PND1 in the
KO, but not WT (p < 0.05; Figure 6D); at day 7 DBP caused a significant increase in P450scc
mRNA levels of the WT but not in the KO (p < 0.05; Figure 6E). At PND60, there were no
detectable concentrations of P450scc mRNA in the hippocampi of any mice (Figure 6F).
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Figure 6: Developmental Expression Profiles of P450scc mRNA in the Cortex and
Hippocampus
A) DBP increased the expression of P450scc mRNA in the cortex at PND 1. There were no
signifcant differences between all the treatment groups. B) KO mice showed a decrease in
P450scc mRNA at PND7 which was significantly increased by gestational exposure to DBP.
Athough there was a decrease in the WT-DBP, the data was not significant. There was a
significant increase in the expression level of P450scc in the KO-DBP compared to all other
treatment groups. C) similar to StAR mRNA expression pattern at PND 60, P450scc mRNA
showed an overall age-dependent decrease in expression compared to PND 1 and 7. DBP
signifcantly decreased the expression of P450scc mRNA in the KO-DBP cortex of PND 60 male
mice. There was also a significant reduction in the expression of P450scc between the WT
control and the KO. D) The expression pattern of of P450scc mRNA in the hippocampus was
similar to the cortex at PND1. DBP signifcantly increased the P450scc mRNA expression in the
KO mice in PND 1. Although there was an increase in the WT-DBP, this result was not
significant. E) at PND7, there was a significant increase in the expression of P450scc mRNA in
the hippocampus of WT-DBP compared to the WT-control and KO at PND 7. There was an
increase in the expression trend of KO-DBP; however, this finding was not significant. F) The
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expression of P450scc mRNA in the hippocampus was not detectable in all groups at PND 60,
indicating an aged-dependent regulation of the expression of P450scc mRNA.
Statistical values are representative of an ANOVA with Tukey’s HSD post hoc test alpha level
0.05% (p < 0.05*). Data represent mean ± SD of at least three independently repeated
experiments.

Our mRNA findings of P450scc at PND 60 were supported by a western blot analysis where we
observed a significant decrease in P450scc protein expression in the testes of WT-DBP mice
compared to the WT – control (p<0.01). In addition, there was a DBP effect in the KO-DBP
mice (p<0.01) (Figure 7, D). These findings were consistent with the western blot analyses of
P450scc in the cortex. There was a decrease in the expression of P450scc in the WT and KO
mice gestationally exposed to DBP (Figure 8, B). Interestingly, in both the testes and the cortex,
DBP reduced the expression of P450scc in the WT to the level of expression observed in the KO
(Figure 7D, Figure 8, B). Exposure of DBP to the KO further reduced the expression of P450scc.
Further confirmations of these findings were observed by an immunohistochemical analysis of
P450scc in the CA3 region of the hippocampus. Gestational exposure of DBP drastically reduced
P450scc expression in both the WT-DBP and KO-DBP mice (Figure: 11-2, B, D)
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Figure 7: Gestational exposure to DBP reduces the expression of StAR and P450 in the
Testis
A) Representative image of a western blot showing immunoreactivity of StAR and Actin in the
testes of PND60 mice. (B) Densitometry analysis of the western blots revealed that gestational
exposure to DBP caused a significant reduction in the expression levels of StAR protein in the
WT and KO mice testes. (B). Bars represent the densitometric ratios of StAR to actin (C).
Representative image of a western blot showing immunoreactivity of P450scc and Actin in the
testes of PND60 mice. (D) Gestational exposure to DBP caused a significant decrease in the
expression levels of P450scc in the WT and KO. KO mice had reduced expression when
compared to control and DBP further decreased the levels on P450scc expression. Bars represent
the densitometric ratios of P450scc to actin.
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Figure 8: Gestational exposure to DBP reduces the expression of P450scc in the Cortex,
and the hippocampus
A) Representative western blot analysis showing the protein expression of P450scc in the cortex
and Hippocampus obtained from PND 60 male offspring mice. Actin was used as an internal
control. B) Gestational exposure to DBP altered the expression of P450scc in the cortex of both
WT and KO mice. In the hippocampus however, DBP did not alter the expression of P450scc in
the WT, but caused a decrease in the KO mice. Bars represent the densitometric ratios of
P450scc to actin

Our analysis of StAR mRNA at PND 7 indicates a reduction in the expression levels in cortex of
WT-DBP mice compared to the WT-control (p<0.05). In addition, this DBP effect was also
observed in the KO-DBP (p<0.01) (Figure 9, B). At PND 60, the expression levels of of StAR
mRNA in the cortex was significantly low compared to early ages. Interestingly, KO mice had
non-detectable levels of StAR mRNA compared to all treatment groups in the PND 60 mice (WT
control vs KO, (P<0.05), WT-DBP vs KO, (P<0.01) and KO-DBP vs KO, (P<0.05) (Figure 9,
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C). Our mRNA findings in cortex of KO of PND 60 concurrent with our western blot analysis
where we observed a decrease in KO expression of StAR. These findings however did not reach
significance Figure 9, A).

Contrary to the findings in PND 1 of the cortex, DBP had a siginicant effect on the StAR mRNA
level at PND 1 in the hippcampus. There was a reduction in the expression of StAR mRNA
expression in the KO mice (p<0.01). Moreover, there was a signficant reduction in the mRNA
expression of KO-DBP (p<0.05) (Figure 8, D). At PND 7, there was a decrease in the expression
of StAR in the KO-DBP (p<0.05) compared to the WT-DBP (p<0.05) at PND 7 (Figure 9, E). At
PND 60, the expression levels of StAR mRNA in the cortex was significantly low compared to
early ages. There was a signifcant reduction in the WT-DBP (p<0.05) and KO (p<0.05).
Interesting, there was a signifcant increase in the KO-DBP (p<0.001) (Figure 9, F).

The western blot analysis showed a significant decrease in the protein expression of StAR at
PND 60 in the cortex of WT mice gestationally exposed to DBP (p<0.05) (Figure 10, D). This
reduction in the StAR expression observed in the WT-DBP matches the low expression of StAR
in the KO mice. The low levels of StAR protein expression in the KO are consistent with the
mRNA findings in PND 60 (Figure 9, C). Although the western blot analysis regarding the
expression of StAR in the hippocampus show no significant difference between the WT and KO
mice gestationally exposed to DBP (Figure 10, E); we observed a decreased StAR expression in
WT-DBP, KO and KO-DBP in the hippocampus (Figure 9, F) in our PND 60 mRNA data.
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Figure 9: Gestational exposure to DBP caused a time-dependent alteration in the
expression pattern of StAR mRNA in the cortex and hippocampus: A) There were no
significant differences in the expression of StAR between all treatment groups at PND 1. WT
mRNA expression was normalized to 100%.B) at PND7, the effect of DBP became more
pronounced. DBP significantly reduced the expression of StAR mRNA in the cortex of both WT
and KO. The DBP-induced decrease in StAR mRNA expression was correlated to the baseline
levels in the WT and KO mice cortices. C) AT P60, the expression levels of of StAR mRNA in
the cortex was significantly low compared to early ages. Interestingly, KO mice had nondetectable levels of StAR mRNA compared to all treatment groups in the PND 60 mice.D) In the
hippocampus, the expression of StAR mRNA was significantly decreased in response to
gestational exposure to DBP. Interestingly, the KO hippocampi showed a significant reduction in
baseline expression of StAR mRNA at PND 1.E) Suppression of StAR mRNA expression in the
hippocampus remained at PND7. There was a significant decrease in the expression of StAR
mRNA in the hippocampus of the KO compared to the WT and WT-DBP. Additionally, there
was a decrease in the expression of StAR in the KO-DBP compared to the WT-DBP at PND 7.
F) similar to the cortal expression, KO StAR mRNA expression was significantly reduced
compared to WT and was increased in response to exposure to DBP. The expression of StAR
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mRNA in the hippocampus of WT-DBP was significantly decreased compared to the WTcontrol and KO-DBP. The expression was also decreased in the KO compared to the WT and
KO-DBP at PND 60.
Statistical values are representative of an ANOVA with Tukey’s HSD post hoc test alpha level
0.05% (p < 0.05*, p < 0.01**, p < 0.001*** and p < 0.0001****). Data represent mean ± SD of
at least three independently repeated experiments.
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Figure 10: Gestational DBP exposure reduces the expression of GAD67 and StAR in
Cortex and the Hippocampus
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(A) Representative image of a western blot showing immunoreactivity of GAD67, StAR and
Actin in the cortex and hippocampus of PND 60 mice. (B) Gestational exposure of DBP
significantly reduced the expression of GAD67 in the cortex of WT and KO mice. In the
hippocampus, DBP caused a slight decrease in the WT and KO expression levels of GAD67 (C).
StAR expression in the WT and KO was affected by gestational exposure to DBP in the cortex
with significant decreases in the WT (D). The expression of StAR was not affected by
gestational exposure to DBP in the hippocampus of both WT and KO mice (E). Bars represent
the densitometric ratios of StAR to actin and GAD67 to actin.
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Figure 11: Expression of P450scc and StAR in the dentate gyrus
Representative images of StAR (A) and P450scc (B) immuno-reactivity in the dendate gyrus of a
WT control mouse. Images were reconstructed from a Z stack obtained with a confocal
microscope and processed using Imaris software. C is a maximum projection of a Z stack.
Images showing co-localization of StAR and P450scc. StAR immunoreactivity is localized to the
endothelial cells of capillaries (A), whereas P450scc is expressed in the endothelial cells and in
the cytoplasm of granule cells of the dentate gyrus (B), Quantification of spatial distribution of
immunoreactivity from a z stack revealed a significant co-localization with distinct spatial
expression of both antigens (D). In the cerebellum, immunoreactivity for StAR and P450scc was
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mainly co-localized to the Purkinje cells cytoplasm (E) with some distinct expression in the
endothelial cells for both antigens. Z stack reconstruction of a high magnification image of a
blood capillary revealed a distinct distribution of StAR and P450scc in the endothelial cells (F).
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KO

KO DBP

WT DBP

C

D

Figure 11-2: Gestational exposure of DBP reduces the expression of StAR and P450scc in
the CA3 region of the hippocampus
Scatter graphs showing the quantification of the immunoreactivity of StAR (red) and P450scc
(green) from hippocampal slices of PND 60 male (A-D). Dots represent individual
immunofluorescence puncta of StAR (red) and P450scc (green). The arced line represents the
threshold of detection above background. The area between the oblique line represent the degree
of overlap or spatial co-localization of the antigens. In (A) there is approximately 13 %
colocalization with distinct labeling for StAR along the x axis and P450 along the y axis.
Gestational exposure to DBP induced a drastic reduction in the expression of StAR and P450scc
as well as their co-localization (B). KO mice had a significant reduction in the expression of
these two proteins (C) that was further decreased upon exposure to DBP in utero (D). The
threshold of detection was lowered in C and D.
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4.3 Gestational exposure to low levels of DBP reduces the expression of GABAergic key
proteins (GABAA β3 and GAD 67) and the VSCC
Our mRNA findings for GABAA β3 showed no significant differences in the cortex. Although the
KO expressed a reduction in the GABAA β3 mRNA levels at PND 1 (Figure 12, A) and PND 7
(Figure 12, B), these changes were not significant compared to all other treatment groups. The
overall expression of the GABAA β3 mRNA levels were significantly reduced at PND 60 (Figure
12, C) compared to all other age groups. The western blot analysis confirmed the reduction in the
GABAA β3 levels later in development. Our findings showed that there was an overall reduction
in the WT-DBP, KO and KO-DBP mRNA expression of the GABAA R in the cortex (Figure 12,
A). We noticed a more pronounced DBP effect in the hippocampus compared to the cortex.
Although we noticed a decrease in the expression of GABAA β3 mRNA levels in the
hippocampus at PND 1, there was a significant increase in the expression of GABAA β3 mRNA
in the KO-DBP mice (p<0.05) (Figure 12, D). This DBP effect was also observed at PND 7 in
WT-DBP mice with an expression higher than all other treatment groups (p<0.01) (Figure 12, E).
At PND 60, DBP drastically reduced the expression of GABAA β3 mRNA in the hippocampus
compared to earlier age groups as observed in the cortex. In addition to the overall reduction in
the expression, there was a significant decrease in the expression of GABAA β3 mRNA of WTDBP (p<0.05) and KO-DBP mice in the hippocampus at PND 60 (p<0.05) (Figure 12, F). The
mRNA findings at PND 60 were consistent with the western blot analysis that showed a decrease
in the expression of the GABAA receptor in the hippocampus of WT and KO mice gestationally
exposed to DBP (Figure 13, B).

36

CORTEX
R e la tiv e m R N A e x p r e s s io n o f G A B A

PND 1

R e la tiv e m R N A e x p r e s s io n o f G A B A

AR

AR

B3

D

B3

HIPPOCAMPUS

A
2 .0

1 .5

1 .0

0 .5

0 .0
W T -D B P

KO

K O -D B P

2 .0

*
1 .5

1 .0

0 .5

0 .0
W T -D B P

KO

K O -D B P

T r e a tm e n t / G e n o ty p e

E

PND 7

R e la tiv e m R N A e x p r e s s io n o f G A B A

AR

B

R e la tiv e m R N A e x p r e s s io n o f G A B A A R B 3

B3

T r e a tm e n t / G e n o ty p e

2 .0

1 .5

1 .0

0 .5

0 .0
WT

W T -D B P

KO

K O -D B P

**
2 .0

1 .5

1 .0

0 .5

0 .0
WT

W T -D B P

T r e a tm e n t / G e n o ty p e

R e la tiv e m R N A e x p r e s s io n o f G A B A

1 .5

1 .0

0 .5

0 .0
W T -D B P

KO

B3

F

2 .0

WT

K O -D B P

AR

B3
R e la tiv e m R N A e x p r e s s io n o f G A B A

PND 60

KO

T r e a tm e n t / G e n o ty p e

AR

C

**

**

K O -D B P

2 .0

1 .5

1 .0

*

*

0 .5

0 .0
WT

W T -D B P

KO

K O -D B P

T r e a tm e n t / G e n o ty p e

T r e a tm e n t / G e n o ty p e

Figure 12: Developmental Expression Profiles of GABA A R β3 mRNA in the Cortex and
Hippocampus
A) In the corteces, DBP had no significant effect on the expression of GABA A R β3 mRNA. KO
mice however showed a reduction in GABA A R β3 mRNA. Similar observation was noted at
PND7 (B) and PND60 (C); however, the overall level of expression of GABA A R β3 mRNA was
significantly reduced compared to earlier age groups. D) In the hippocampus, DBP had more of
an effect. While KO mice had reduced expression of GABA A R B3 mRNA, gestational exposure
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to DBP caused a significant increase in the expression of GABA A R B3 mRNA at PND 1. At
PND7, only WT was affected by gestational treatment with DBP (E). The expression level of
GABA A R B3 mRNA in the hippocampus of WT-DBP was significantly higher compared to all
treatment groups at PND 7. At PND 60 however, DBP had the opposite effect and caused a
drastic and significant reduction in GABA A R B3 mRNA in both WT and KO mice (F). Similar
to the cortex expression, the overall level of expression of GABA A R B3 mRNA was
significantly reduced compared to earlier age groups examined.
Statistical values are representative of an ANOVA with Tukey’s HSD post hoc test alpha level
0.05% (p < 0.05* and p < 0.01**). Data represent mean ± SD of at least three independently
repeated experiments.
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Figure 13: Gestational DBP exposure reduced expression of GABA A R δ C-20 in the Cortex
and Hippocampus
(A) Representative image of a western blot showing immunoreactivity of GABA A R δ and Actin
in the cortex and hippocampus of PND60 mice.
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Gestational exposure to DBP had a slight but not significant effect on GABA A R δ expression in
the WT cortex of both WT and KO mice (B) DBP caused a decrease in the expression levels of
GABA A R δ in the hippocampus of both WT and KO mice. KO mice had reduced expression
when compared to control and DBP further decreased the levels GABA A R δ expression. (C). The
KO mice had a reduction in the expression of GABA A R δ consistent with previous findings in
both the hippocampus. Bars represent the densitometric ratios of GABA A R δ to actin.
The GAD 67 mRNA expression was reduced in the cortex of WT-DBP and the KO-DBP mice at
PND 60 (Figure 14). These cortex findings were supported by the western blot analysis that
showed a significant decrease in the WT-DBP (p<0.05) and the KO-DBP (p<0.01) (Figure 10,
B). Interesting, the GAD67 mRNA was significantly higher in the KO mice. In the hippocampus,
DBP caused a slight decrease in the WT and KO expression levels of GAD67 (Figure 10, C).

Figure 14: Expression of GAD67 mRNA in the Cortex
Gestational exposure of DBP significantly reduced the expression of the GAD67 mRNA in the
cortex of WT administered with DBP compared to the WT control. The expression of GAD67
was further decreased in the KO mice exposed to DBP at PND 60.
The mRNA expression levels of the VSCC β3 in the cortex were not significantly different at
PND 1, 7 and 60 (Figure 15, A-C). Although these changes were not significant, there was an
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age-dependent decline in the expression of the VSCC β3 at PND 60 (Figure 15, C). The western
blot analysis showed decreases in the WT-DBP and KO-DBP. The expression of the VSCC β3
was significantly reduced (p<0.05) in KO gestationally exposed to DBP compared to the WTcontrol (Figure 16, B). Although the overall mRNA expression of the VSCC β3 in PND 60 was
reduced in all treatment groups compared to the WT-control, we observed no significant
differences in the western blot analysis regarding the expression of VSCC β3 of WT-DBP, KO
and KO-DBP.
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Figure 15: Developmental Expression of VSCC mRNA in the Cortex and Hippocampus
a) Gestational exposure to DBP had no pronouced effects on the the expression of the VSCC β3
mRNA in the cortex at the various age groups examined PND1 (A); PND7 (B); PND60 (C).
there was however an age-dependent decline in the expression of the VSCC β3 mRNA in the
cortex D) In the hippocampus, DBP treatment had more of an effect compared to the cortex
depending on the age examined. At PND1, DBP had a trancription-suppressor effect on KODBP mice hippocampi (D) and translation enhancer on WT hippocampi (E). At PND 60, the
overall expression of the VSCC β3 mRNA was reduced with the WT controls showing the
highest level of expression (F).
Statistical values are representative of an ANOVA with Tukey’s HSD post hoc test alpha level
0.05% (p < 0.05*). Data represent mean ± SD of at least three independently repeated
experiments.
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Figure 16: Gestational exposure to DBP reduced expression of VSCC in the Cortex and
Hippocampus
(A) Representative image of a western blot showing immunoreactivity of VSCC and actin in the
cortex and hippocampus of PND60 mice.
Gestational exposure to DBP reduced the expression of VSCC in the cortex of both WT and KO
mice (B). DBP had no significant differences in the expression levels of VSCC in the
hippocampus of WT and KO mice (C). Bars represent the densitometric ratios of VSCC to actin.

Gestational exposure of low levels of DBP reduces the expression of NKCC1 and KCC2

Both GABA-mediated inhibition and excitation depend on postsynaptic activation of GABAA-R,
a multimeric ionotropic receptor that primarily promotes facilitated chloride (Cl-) diffusion. In
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the early developmental stages, the intracellular Cl- concentration is higher than the extracellular
concentration. GABAA-R activation therefore stimulates Cl- efflux, depolarizing the neuronal
membrane (Ben-Arie, 2007), promoting the L-type voltage-sensitive calcium (Ca2+) channels
activation, and triggering the GABA trophic effects through Ca2+-mediated intracellular
signaling (McCarthy, 2008). Two major cation-chloride cotransporters are NKCC1, which
imports Na+/K+/Cl−, and KCC2, an exporter of K+/Cl−(Ben-Ari et al., 2007; Delpire, 2000,
Jansen et al., 2010). NKCC1 is highly expressed in immature neurons, whereas KCC2 is
expressed in low levels (Dzhala et al., 2005; Nuñez et al., 2007; Wang et al., 2002). This
contributes to GABA-mediated excitation through neuronal membrane depolarization. The
expression of these symporters is regulated by GABA-mediated depolarization and by steroid
hormones in the substantia nigra and hippocampus (Galanopoulou et al., 2003, Galanopoulou,
2008). Expression of these co-transporters is crucial for the normal developmental tragectory of
the brain and is sensitive to alterations in neurosteroidogenesis.
We found that DBP had an effect at PND 7, NKCC1 mRNA expression was significantly
suppressed in the KO mice compared to the KO control (p<0.01) (Figure 17, B). Although the
overall levels of the NKCC1 mRNA were reduced age-dependently, the supression of
transcription by DBP in KO mice remained greatest at PND 60 (p<0.01) (Figure 17, B). In the
hippocampus, gestational exposure to DBP had more pronounced effect on the NKCC1 mRNA
expression. At PND1, DBP increased the mRNA expression of NKCC1 in the WT hippocampi.
KO mice had a significant increase in NKCC1 mRNA expression compared to the WT- control
(p<0.01) (Figure 17, D). These elevated levels of NKCC1 mRNA expression was also obsered in
the KO hippocampi at PND7. KO exposed to DBP had a significant suppression in the
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expression of NKCC1 mRNA (Figure 17 E). DBP caused a significant descrease in expression of
NKCC1 in the WT (p<0.01) and KO mice (p<0.01) (Figure 17, F).
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Figure 17: Developmental Expression NKCC1 mRNA in the Cortex and Hippocampus
A) At PND1, DBP had no significant effect on NKCC1 mRNA expression in the cortex.
However at PND7, DBP significantly suppressed NKCC1 mRNA expression in the KO mice
(B). Baseline NKCC1 mRNA expression in the KO mice was significantly higher than WT at
PND7 (B). Supression of transcription by DBP in KO mice remained at PND60 (C). The overall
levels of expression of the NKCC1 mRNA were reduced age-dependently. D)In the
hippocampus, gestational exposure to DBP had more modulating effects on the NKCC1 mRNA
expression. At PND1, DBP caused more than a two folds increase in the NKCC1 mRNA
expression in the WT hippocampi. KO mice had a significant increase in NKCC1 mRNA
expression was remained unaffected by DBP. The elevated levels of NKCC1 mRNA expression
was also obsered in the KO hippocampi at PND7 (E). However, at this age DBP caused a
significant supression in the expression of NKCC1 mRNA. DBP caused a significant decrease in
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expression of NKCC1 mRNA. FMR1 KO mice had reduced rexpression compared to WT which
was not affected by DBP (F).
Statistical values are representative of an ANOVA with Tukey’s HSD post hoc test alpha level
0.05% (p < 0.05* and p < 0.01**). Data represent mean ± SD of at least three independently
repeated experiments.

Our investigation of mRNA expression showed that gestational exposure to DBP caused a
significant increase in the expression of KCC2 mRNA in the KO mice in the cortex (p<0.05)
(Figure 18, A). Although there was an overall reduction in the expression level of KCC2 at
PND7, there was no DBP effect on all treatment groups (Figure 18, B). At PND 60, DBP
suppressed the expression of KCC2 mRNA in the KO mice (p<0.05) compared to the other
groups examined (Figure 18, C). In the hippocampus of PND1 mice, KO mice had a significant
decrease in the expression KCC2 mRNA, which as slightly but not significantly increased in
response to gestational exposure to DBP (18, D). At PND7, KO mice hippocampi showed a
significant elevation in the expression of KCC2 mRNA compared to all treatment groups
(p<0.01). This expression was suppressed in response to DBP (p<0.01) (Figure 18, E). There
were no significant differences in the expression of KCC2 between all treatment groups at PND
60. (Figure 18, F).
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Figure 18: Developmental Expression KCC2 mRNA in the Cortex and Hippocampus
A) In the cortex, gestational exposure to DBP caused a significant increase in the expression of
KCC2 mRNA in the KO mice (A). There was a slight but not significant increase in KCC2
mRNA expression in the WT in response to DBP (A). DBP had no effects on KCC2 mRNA
expression at PND7 in the WT; however, there was a significant reduction in the expression of
KCC2 mRNA in the KO mice. There was an overall reduction in the KCC2 expression level
observed at this age (B). At PND60, DBP suppressed transcription of KCC2 mRNA. This
transcriptional suppressive role was more pronounced in the KO mice (C). KO mice exposed to
DBP in utero had a significant decrease in the KCC2 mRNA expression compared to the other
groups examined (C). (D) In the hippocampus of PND1 mice, KO mice had a significant
decrease in the expression KCC2 mRNA, which as slightly but not significantly increased in
response to gestational exposure to DBP (D). At PND7, KO mice hippocampi showed a
significant elevation in the expression of KCC2 mRNA which was significantly suppressed in
response to DBP (E). Similar trend was observed at PND7 but the changes were not significant
(F).
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Statistical values are representative of an ANOVA with Tukey’s HSD post hoc test alpha level
0.05% (p < 0.05*, p < 0.01** and p < 0.001***). Data represent mean ± SD of at least three
independently repeated experiments.

Gestation exposure of DBP affects neuronal excitability later in development
We tested the threshold for seizure induction as an index for the potency of the GABAergic
system. We found that the offspring of DBP-injected mice had a significant decrease in the
threshold of limbic seizures as measured by reduced latency (p <0.01) (Figure 19, B), decreased
duration (p <0.01) (Figure 19, A) and increased mortality rate in response to kainic acid injection
(15mg/kg BW). The decreased duration of seizures was due to increased mortality rate during
the status epilepticus phase of convulsions. These findings of increased neuronal excitability
were consistent with the electrophysiological data using subthreshold concentrations of kainic
acid (5mg/kg/BW).

**
**

Control: N= 5 Males

DBP: N= 6 Males

Figure 19: Gestational exposure to DBP lowers the threshold and increases severity for
seizures in PND 60 male mice
Gestational exposure to DBP significantly reduced the duration of KA-induced seizures (A). The
reduced duration was due to increased mortality rate in mice exposed to DBP in utero (A).
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Lower threshold for seizures was also evident by the reduced latency to the onset of seizures (B).
DBP exposed mice showed a significant reduction in the latency to the onset of seizures (B).
Data represents ±SEM of latencies to seizures onset post kainic acid injection (15mg/kg BW)
obtained from the offspring of DBP-injected or control pregnant mice. Control: N=6, DBP: N=6.
**p <0.01

Our data from in vivo electrophysiological recordings from the cortex of DBP exposed mice
showed that they experienced higher frequency seizure activity with subthreshold kainic acid
injections compared to the WT controls (Figure 20: D2, D4). Furthermore, the KO mice, with
low threshold for limbic seizures, were exceptionally susceptible to KA injection and showed an
increased frequency and amplitude of neuronal discharge. (Figure 20: D4).
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Figure 20: Electrophysiological recording of cortical neuronal activity following kainic acid
administration
Gestational exposure to DBP increases neuronal excitability and reduces seizure threshold
following Kainic acid administration a) Representative electrophysiological traces obtained
from a cortex of a WT mice showing the response to kainic acid (KA). Subcutaneous injection
of 15 mg/kg induced synchronization of neuronal discharge followed by an epileptiform
discharge (A). Base line recording shows high frequency and low amplitude waves. After
injection of KA, neuronal circuits that subserve KA-induced seizures synchronized their activity
which preceded the onset of seizures (A) We used this set up to determine susceptibility to KA
and seizure threshold by measuring the latency to the onset of ictal activity, their duration and
frequency (B). KA dose was reduced to 5 mg/kg to measure neuronal excitability without onset
of seizure since the animals were stereotaxically immobilized (B). Low doses of KA (5mg/kg)
induced ictal activity approximately 45 min post injection. (C) Electrophysiological recordings
from the cortex showing baseline activity in the WT, KO ± DBP. In the WT cortex, electrical
activity was characterized by a low frequency low amplitude waves which were intermittently
interrupted by episodes of slightly lower frequency and higher amplitudes waves typical of
synchronization. The three traces represent the recording from the three cortical electrodes.
Shown here is a 15 sec baseline recording (C). KO mice showed and elevated neuronal
excitability levels. Gestational exposure of WT or KO mice to DBP resulted in an elevated
neuronal discharge at baseline typified by high frequency and elevated amplitude (C). Injection
of 5 mg/kg KA induced an epileptiform discharge in the WT approximately 45 min post
injection (D). KO mice showed the same response with elevated amplitude. DBP reduced the
latency for the onset of the epileptiform discharge in both WT and KO mice (D).
Gestational exposure of DBP affects neurobehavior later in development

As normal behavior of mice is dependent on a normal functioning GABAergic system that is not
compromised, we hypothesized that the down regulation of the steroidogenic key proteins
(P450scc and StAR), GABAergic proteins (GAD67, GABAAR), VSCC and the co-transporters
(NKCC1 and KCC2) would affect how the mice behaved. These proteins work in a combined
effort to establish neuronal formation and networks early in development.

The OF tests for hyperactivity and anxiety showed that male WT-DBP mice and KO-DBP mice
(p<0.05) experienced hyperactivity, as evidenced by the increase in the total distance travelled
compared to the WT- control (Figure 21, C). KO and KO-DBP mice were extremely hyperactive
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and spent an increased amount of time in the center zone compared to the WT- control (Figure
20, D).

C

D

Figure 21: Gestational DBP exposure of 1mg/kg BW increases hyperactivity in the PND 60
male offspring mice
Track plot tracing of mice in the open field arena showing the path of mice during the recording
time. KO mice (B) traveled significantly more that WT (A) indicative of hyper-activity. (C) The
Open Field Test showed that DBP had a genotype-and gender-specific effect as the KO & KODBP male mice exhibited an increase in total distance travelled compared to the male WT mice.
The female mice showed the opposite compared to the male mice. All other female treatment
groups (WT-DBP, KO, and KO-DBP) had a decrease in the total distance travelled compared to
the female control WT. In addition, there were no significant differences between all four
treatment groups.
(D) Male mice exposed to DBP showed an increase in the time spent in the center zone.
Although the data was not significant, the male KO and the KO-DBP showed an increase
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compared to the WT and WT-DBP. The female mice showed no significant difference across all
treatment groups.
These results suggest that DBP treated mice shows pronounced effects of hyperactivity.
Statistical values are representative of a Factorial ANOVA with Unequal -Tukeys HSD post hoc
test alpha level 0.05% (p< 0.05* and p < 0.01**).

The EPM assay that assessed anxiety provided evidence that WT-DBP mice (p<0.05) and KODBP mice (p<0.001) were anxious, as demonstrated by the reduced number of entries into the
open arm compared to the WT – control (Figure 22, C). Additionally, the WT-DBP mice spent
significantly less time immobile compared to the controls. Furthermore, the KO mice that are
already predisposed to elevated anxiety levels due to decrease expression of GABAARs,
experienced elevated anxiety levels as shown by the decreased number of immobile episodes.
KO-DBP mice experienced a further decrease and as a result had an elevated anxiety level
compared to all treatment groups. (Figure 22, B).
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Figure 22: DBP caused hyperactivity and anxiety in the WT and KO mice of PND 60 male
offspring mice in the elevated plus maze
A) Representative track plots showing motoric activity in an elevated plus maze. Mice were
tracked for 5 min. Control mice spent approximately 20 % of the test time exploring the open
arm of the apparatus, shown here in the vertical position. Figure: b) when the animals stop
moving in the open arm, it is an indication of reduced anxiety, as they become comfortable
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within that zone. (B) The number of immobile episodes in the open arm of the elevated plus
maze. Animals from the four groups spend equal time immobile in both the closed and center
zone. However, in the open arm WT-DBP mice spend significantly less time immobile compared
to WT. Interestingly, KO mice ± DBP spend significantly less time immobile in the open arm
indicative of elevated anxiety. (C) Entry into the open arm represents an exploratory behavior of
mice that is inhibited by elevated anxiety. WT mice spend more time exploring the open arm
compared to KO mice. These are known to have elevated anxiety. Gestational exposure to DBP
proportionally suppressed the number of entries into the open arm in both WT and KO (C)
Statistical values are representative of an ANOVA with a Tukeys HSD post hoc test alpha level
0.05% (p< 0.05* and p < 0.001**).

We followed up the behavioral analysis by assessing the expression of emotional fear learning
and memory. The context fear task that accesses memory based on the animals ability to
associate light, sound and shock provided findings that WT mice learned to associate contextual
cues with predictive foot shock as expected during all 4 trials (Figure 23, A). In contrast WTDBP, KO and KO-DBP evidenced decreased ability in using contextual environmental cues
when associating foot shock in this test after the 4th trail. WT-DBP (p<0.05) showed a significant
exaggerated fear response compared to all treatment groups. 24 hours later, the percent time
spend freezing decreased in the WT-DBP and the values were the same for all treatment groups.
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Figure 23: Gestational exposure of DBP alters learning in the Context Fear Paradigm
Figure 23 illustrates the influence of environmental context with associating aversive stimuli to
produce a learned fear response (freezing) in a trained vs. a novel alternate contextual
environment to assess the behavioral expression of emotional fear learning and memory. WT
mice learned to associate contextual cues with predictive foot shock without issues during the 4
trials. In contrast WT-DBP, KO and KO-DBP evidenced decreased ability in using contextual
environmental cues when associating foot shock in this test after the 4th trial. Interestingly, KO
mice showed reduced contextual processing when compared to all groups during trials 3 and 4
indicative of context dependent learning delays and inattentive processing during this test. On the
next day, when probed for retention to assess context evoked fear WT, WT-DBP, KO and KODBP mice showed similar fear responses with stable freezing responses above baseline levels
with some memory decay. We then tested the animals the following day to determine whether
this fear response was context specific by introducing the animals into a novel alternative
environment and observed no differences in treatment groups with freezing levels lower than
baseline suggesting that the acquired fear traits were in fact context specific.
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Figure 23-1 Gestational exposure of DBP alters learning in the Context Fear Paradigm
Figure 23-1 illustrates the influence of tone and light cues with associating aversive stimuli to
produce a learned fear response (freezing) in a trained vs. a novel alternate contextual
environment to assess the behavioral expression of emotional fear learning and memory. WT
mice learned to associate contextual cues with predictive foot shock without issues in a linear
progressive manner during the 4 trials. In contrast WT-DBP mice showed an elevated fear
response that remained ~ 75% higher throughout testing. Interestingly, KO and KO-DBP mice
had difficulty associating the information and exhibited hyperactivity (which reduced freezing)
across all trials. When tested the next day to the sound and light without shock the WT, KO, and
KO-DBP mice recalled an appropriate freezing response based on the prior days training and
were not different from each other. However, WT-DBP continued to exhibit elevated fear with
enhanced freezing behavior to the light and sound. This suggests that KO and KO-DBP mice did
learn the test despite hypermotor activity that diminished their freezing score during training in
direct response to the aversive foot shock. The following day we then tested whether this fear
response was cue specific by introducing the animals into a novel alternative environment and
observed no differences in treatment groups with freezing levels lower than baseline with the
most suppression of freezing behavior exhibited by the WT-DBP group suggesting that the
acquired fear traits were in fact context specific.
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The passive avoidance task, another test that test memory further supported these findings. The
offspring of DBP – injected mice showed altered passive avoidance learning and retention
(p<0.01) (Figure 24).

Figure 24: Acquisition and retention of a passive avoidance task in mice. Each animal was
familiarized with the behavioral apparatus for 2–3 min the day before the training session. All
training and testing was carried out between 08:00 and 12:00 h. Data represent the mean ± SEM
of latencies to the end of the trial over a period of three days (6 trials a day) obtained from
Controls: 6 males, 5 females); DBP (6 males, 6 females) * p<0.01WT males and females
showed a significant learning over time. Both genders learned the task equally well. Gestational
exposure to DBP significantly suppressed leaning in males compared to females. When we
measure retention of the task three days later, we found that retention was highly correlated to
the acquisition level on the last day of training.

Using the Morris water maze as a parameter for learning, we found mice exposed to DBP
travelled much longer distances to find the hidden platform; therefore, the latency to find the
platform was high compared to the WT control (Figure 25).
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Figure 25: Gestational DBP exposure impairs spatial learning and memory in the Morris
Water Maze of PND 60 offspring mice

a) Morris water maze learning for FVB-129 and Fmr1 knockout mice ± DBP. Blocks of six
training trials given on each of the four consecutive days. Data represent the mean ± SEM of the
distance travelled (m) to find the hidden platform. WT mice showed a significant decrease in the
distance traveled to find the platform overtime. KO mice, although showed learning over time
the time spent finding the platform was significantly higher compared to control WT.
Interestingly, WT exposed to DBP showed the same level of learning as the KO, which was
significantly lower than control WT. Gestational exposure to DBP completely abolished learning
in the KO mice (A). Distance traveled to find the hidden platform as a measure of learning was
associated with a decease velocity of mice. This is indicative of confidence in finding the
platform (B). WT mice not only they traveled shorter distance to find the platform (A) but they
also swim slower (B). Interestingly, WT were significantly different that all other groups in term
of swimming velocity (B), indicating an increased anxiety in the other groups compared to
controls.
The social interaction study showed that mice that were exposed to DBP spent less time
socializing with a novel mouse compared to the WT control. There was a significant reduction
observed in the KO mice that were exposed to DBP prenatally (Figure 26)
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Figure 26: Gestational exposure to DBP reduces socialization and the time spent socializing
in the PND 60 offspring mice
Behavioral performance of WT± DBP and KO±DBP in the three chambered social interaction
apparatus showed a DBP effect on socialization.
a) #1Three chambered social interaction apparatus: #2 Socializing is denoted as sniffing,
following, crawling and grooming. # 1 - Test mouse’s natural preference of darkness over
unfamiliar stranger. Gestational exposure to DBP induced a reduction in the number of social
interactions and the time spent socializing in both WT and KO mice (B, C, D, and E
respectively). All training and testing was carried out between 08:00 and 12:00 h. Data represent
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the mean ± SEM of number of social interactions and time spent socializing obtained from at
least 6 animals in each group.

DISCUSSION

THE EFFECTS OF ACUTE EXPOSURE OF DBP ON NEUROBEHAVIOR

Low levels of DBP affect the neurobehavior of 2 month aged mice

Our initial studies began with investigating the acute effects of DBP exposure on
neurosteroidogenesis in the brain of 2 month aged mice. Studies attempting to identify the
detrimental effects of DBP exposure in rodents have by and large focused on the male testes
(Thompson et al., 2004; Hallmark et al., 2007; Higuchi et al. 2003). While there has been
tremendous progress in gathering evidence in the peripheral organs like the testes, there are
limited studies elucidating the effects of DBP on neurosteroids in the brain. This is clearly
evidenced by the limited number of research published articles (Li et al., 2013; Li et al., 2014)
since the ground-breaking discovery that the brain synthesizes its own steroids de novo (Baulieu,
1998). We embarked on a major effort to investigate whether low levels of DBP (1 mg/kg BW
i.p) would show significant behavioral alterations. Our findings showed that adult male and
female mice at postnatal day 60 (PND 60) injected with DBP (1 mg/kg BW s.c) showed
significant neurobehavioral differences, characterized by decreased locomotor activity in the
open field test. These effects were observed 15 min post DBP injection, indicating a fast acting
mechanism. These findings suggested that gestational exposure of DBP would elicit a slower
acting mechanism that may target key proteins and mechanisms involved in neurodevelopment.
In order to understand the underlining mechanisms that may affect early brain development, we
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targeted the critical period of neurogenesis by injecting pregnant dams with the same low dose of
1 mg/kg BW of DBP.

To determine the functional consequences of gestational exposure of DBP on endocrine
functions and how it regulates neuronal maturation, we investigated the key proteins involved in
neurosteroidogenesis, P450scc and StAR. These critical neurosteroidogenic proteins are
responsible for converting cholesterol to steroid hormones in the mitochondria. Steroid hormones
exert genomic and non-genomic effects by altering steroid-dependent gene transcription and by
allosterically modulating ion channels, respectively. Among the ion channels that are
allosterically modulated by steroid hormones, GABA A receptors are critical. Early in
development, the establishment of immature neuronal networks is critically dependent on
GABAergic function through the activation of GABAARs (Ben-Ari, et al., 2007). These
receptors are substrate for allosteric modulation by neurosteroids as part of their non-genomic
effect. In addition, neurosteroids have been reported to increases the expression of GAD, which
consequently increases the synthesis of the neurotransmitter GABA in inhibitory interneurons
(Mong et al., 2002). We hypothesized that disrupting normal neurosteroidogenesis will lead to
altered steroid-dependent gene expression (genomic) and loss of allosteric modulation of ion
channels (non-genomic). As DBP is an endocrine disrupter, we expected this phthalate to
interfere with neurosteroidogenesis in the brain. Furthermore, the disruption of these key
neurosteroidogenic protein would interfere with the maturation of the GABAergic system. As a
result of our acute behavioral findings, we examined the effects of DBP on the expression of the
key proteins involved in neurosteroidogenesis, P450scc and StAR.
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THE EFFECTS OF GESTATIONAL EXPOSURE OF DBP ON THE KEY PROTEINS
P450SCC and STAR IN THE NEUROSTEROIDOGENEIC PATHWAY

DBP alters the expression of P450scc and StAR mRNA levels during brain development
but reduces the expression later in development.

Our studies revealed that gestational exposure to a single dose of DBP (1mg/kg s.c) affected the
expression of P450scc and StAR in the cortex and hippocampus. Given the low levels of StAR
expression in the brain coupled with the difficulties to detect this protein by biochemical
techniques; we chose the cortex and hippocampus since these two brain regions have been
reported to express slightly higher levels of StAR (King et al., 2002, Kimoto et al., 2001).
Striking differences of these steroidogenic proteins’ mRNA levels were observed at different
developmental stages in the WT and KO mice.

The effect of DBP on early development (PND 1 and 7) mRNA analysis of P450scc showed that
DBP increased the mRNA expression of this protein in the cortex and hippocampus of WT and
KO mice. This increase in mRNA expression could be a protective neuronal response to DBPinduced neuronal toxicity as has been previously reported (King et al. 2001, McCarthy 2008). In
addition, in cases of neurodegenerative diseases such as Alzheimer’s disease, there is an increase
in the expression of StAR in hippocampal pyramidal neurons (Webber et al. 2006). Moreover,
similar observations by Kimoto et al. 2001; Sierra et al. 2003 reported that excitotoxic stimuli
such as kainic acid and NMDA stimulated the synthesis of P450scc and StAR in the
hippocampus. Thus, the observed increase in StAR and P450scc mRNA expression could be due
to the DBP-mediated neuronal insult. Although the WT exposed to DBP showed a decrease in
the level of P450scc during early development, the changes in the expression levels were not
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significant compared to the WT control. At PND 60, there was a significant reduction in the
expression of P450scc in the KO mice. DBP induced further decease in P450scc mRNA
expression. This decrease was further confirmed by biochemical analyses. In addition, the WTDBP also showed a significant reduction in the expression of P450scc in the testes, consistent
with previous findings (Thompson 2004). Analysis of StAR during development (PND 1)
showed a significant decrease in the expression levels in the hippocampus of all treatment groups
compared to the WT controls in response to gestational exposure to DBP. Furthermore, this
decrease in StAR mRNA expression was also observed in the WT and KO cortex including the
hippocampus of PND 7 mice treated with DBP. The expression was further decreased in the
cortex at PND 60 in both WT and KO mice treated with DBP. This observation was also
consistent in the hippocampus; however, the KO-DBP in this brain region expressed slightly
higher levels of StAR mRNA compared to the WT-DBP and KO mice. The western blot analysis
in the hippocampus concurred with the reduction in StAR expression in the WT-DBP and KO.
Although there was an increase in the mRNA of the KO-DBP at PND 60, the western blot
showed a decrease in the expression in this treatment group. The immunohistological analysis of
the StAR protein at PND 60 was consistent with reduction in the mRNA levels observed in both
the WT and KO mice exposed to DBP. Taken together, the alterations in P450scc and StAR by
DBP early in development can affect the synthesis of neurosteroids. As a result, they can affect
maturation of the GABAergic system. N Studies have reported that a reduction in the expression
of these proteins in the brain led to decreased synthesis of neurosteroids., which in turn resulted
in decreased cell proliferation, increased cell death, altered spine densities and a significant
effect on axonal out growth in vitro (King et al., 2011). These supporting data point to the
evidence that interference with these critical neurosteroidogenic proteins may affect or
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compromise the efficacy of the GABAergic system early in development. Later in development,
the continued expression of these neurosteroids is also critical. Neurosteroids have been reported
to have a neuroprotective role in the brain (King et al. 2001, McCarthy, 2008), but most
importantly, their presence aids in regulating the threshold of seizure susceptibility in individuals
with catamenial epilepsy and temporal lobe epilepsy (Kim et al., 2009; Reddy 2009).

To conclude, the expression of P450scc and StAR during development is critical in the formation
of neurons and the neuronal network. These steroidogenic proteins aid in the establishment of
neuronal networks by synthesizing neurosteroids that are important for the maturation of
GABAergic system. Later in development, they continue to allosterically modulate GABAARs
and as a result, protect the brain from seizure susceptibility. Collectively, these findings illustrate
the importance and significance of neurosteroids and the role they play with regards to the
GABAA receptors. Most importantly, they highlight the central role that they have early in
development and the possible consequences that may transpire in their absence if affect by DBP.

THE EFFECTS OF GESTATIONAL EXPOSURE to DBP ON THE EXPRESSION OF
GABAERGIC PROTEINS: GABAA R and GAD67
DBP increases the expression of GABAAR and GAD67 mRNA levels early in development.

Tremendous progress has been made in investigating the cellular and molecular mechanisms of
neurosteroids in the brain. Most importantly, studies have focused on how neurosteroids like
estrogen synergistically works with the GABAergic system in the brain (King et al., 2011;
McCarthy, 2008). Steroid hormones like pregnanolone and estrogen have been reported to
influence the GABAergic system both early and later in development by exerting genomic and
non-genomic effects (Baulieu 2001, McCarthy 2008). The neurosteroid pregnanolone
63

allosterically modulates GABAARs and increases the influx of chloride ions into the cells
(Baulieu 2001), increasing therefore the efficacy of the GABAergic system. Additionally, early
in development, steroid hormones like estrogen have been reported to augment the excitatory
actions of GABA by increasing the amount of calcium influx, increasing the magnitude of the
response to GABA. The vital role of estradiol orchestrating the excitatory actions of GABA aids
in the regulation of dendritic growth, spine generation and synaptogenesis (McCarthy 2008). In
concordance with these activities, estrogen increases the expression of GAD, which
consequently increases the synthesis of the neurotransmitter GABA by neurons (Mong et al.,
2002). Our findings illustrated that GABAARs are affected by DBP early and later in
development as demonstrated with the steroidogenic proteins. Analysis of the mRNA levels of
GAD 67, the enzyme responsible for synthesizing GABA and GABAAR concurred with the
same findings exhibited in our steroidogenic proteins.
Early in development at PND 1, there was a decrease in the expression of the GABAAR β3
subunit in the WT-DBP and KO in both the cortex and hippocampus. The reduction in the KO
mice was consistent with the findings by El Idrissi et al., (2005) that reported that KO mice
exhibited a down regulation of GABAAR β3 subunit. On the other hand, the KO-DBP at PND 1
showed an increase in the mRNA expression of GABAAR β3 in the hippocampus. Interestingly,
there was no difference in the GABAAR β3 at PND 7 in all treatment groups except for the
increase in the protein expression observed in WT-DBP hippocampi region. These findings were
interesting because the GABAAR β3 expression pattern was consistent with the P450scc patterns
in early development. The reduction in the GABAAR β3 mRNA expression at PND 60 was
consistent with the western blot analysis where there was a reduction in the mRNA levels of the
WT and KO mice exposed to DBP. The reduction in the expression of GABAAR β3 could affect
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the formation of GABA A R in neurons including their networks. We conducted an mRNA and
western blot on the enzyme that synthesis GABA, GAD 67 and found that this enzyme was also
reduced in the WT and KO mice gestationally exposed to DBP at PND 60. Taken together, the
decrease in the GABAergic proteins could affect the course of neurodevelopment.

At early developmental stages, establishment of immature neuronal networks are critically
dependent on the GABAergic function through activation of the GABAA receptors (Ben-Ari, et
al., 2007). During this critical period (PND 1 - 7), neural transmission is the strongest driving
force for synapse formation and maturation, with sensory input and spontaneously generated
patterns of brain activity appearing to have large impact on the development of cortical circuits
(Katz & Shatz, 1996; Leinekgel et al., 2002). In the mouse hippocampus, during PND 2-6, there
are studies that have reported that neurons become highly synchronized through a synergistic
excitatory action of both glutamate and GABA to elicit “Giant depolarizing potentials” (GDPs),
in part due to the opening of VSCC (Leinekgel et al., 1997; Kasyanov et al. 2004; Ben-Ari et al.
2007).GDPs have been shown to facilitate the firing of intrinsically bursting CA3 pyramidal
neurons (Sipila et al., 2005) and increase synaptic efficacy with efferent CA1 neurons
(Mohajerani et al., 2007). These effects are all the result of an “intact” GABAergic system. The
reduction in GABAAR β3 by DBP early in development could cause a decrease in this synchrony
of events that help in establishing neuronal networks. In addition, the down regulation of the
GABAARs in the GABAergic system observed in 2 month aged mice has been connected with
the symptoms exhibited in autism related disorders. Neurobehavioral symptoms ranging from
hyperactivity, anxiety and decrease in social activity have been documented as a result of the
reduction in this protein expression (El Idrissi et al., 2005).
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THE EFFECTS OF GESTATIONAL EXPOSURE OF DBP ON THE L-TYPE VOLTAGE
SENSITIVE CALCIUM CHANNELS (VSCCs)
DBP decreases the expression of VSCC mRNA.

Maturation of neuronal networks requires the synergistic interaction between the L-type VSCCs
and GABA A Rs. Early in development both of these ion channels contribute to neuronal
excitability and responsible for the onset of GDPs. GDPs control neurogenesis through the action
of co-transporters, GABA A Rs and VSCC. Analysis of the mRNA for VSCCs showed that there
was a decrease in the expression levels at PND 1 in the hippocampus of all treatment groups with
a significant decrease in the KO exposed to DBP. There were no significant differences in the
expression of the VSCCs at PND 7 in the cortex and hippocampus. At PND 60, there was
decline in mRNA expression of this protein that was consistent with the western blot analysis
that showed significant reduction in the expression of the VSCC in the hippocampus at PND 60.

The release of the neurotransmitter GABA is dependent on the activation of VSCCs. These
channels play a significant role in calcium dependent-gene expression and calcium mediated
release of neurotransmitters (Ben-Ari et al., 1994; Catterall, 2011; Flavell and Greenberg, 2008).
A study in 2009 reported that blocking calcium influx through L-type VSCCs reduced the
expression of GABAARs (Saliba et al., 2009). Reduction in the GABAARs is associated with
autism-like symptoms (El Idrissi et al., 2005). It is evident that the proper functioning of the
VSCCs is critical especially early in development; interference or malfunctioning of this channel
can derail normal brain development.
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DBP increases the expression of NKCC1 and KCC2 mRNA levels early in development

The notion that neurosteroids alone run the operation of keeping an “intact” GABAergic system
is not quite complete. Although the GABAergic system with the aid of neurosteroids are the
driving force that aid in the development of neuronal networks early in development, there are
key transporters that assist this operation (Ben-Ari, 2002). The co-transporters - NKCC1 and
KCC2 are responsible for controlling the developmental shift in GABA from excitatory to
inhibitory in immature neurons (Hasbargen et al., 2010). With this vital piece of information, we
proceeded to examine whether these two co-transporters are affected by DBP exposure. In
addition, we were curious to see whether any changes in the expression of these proteins could
affect development later. Our previous studies (Xin dissertation – unpublished data) showed that
there was a developmental delay in the switch from excitatory to inhibitory in KO mice.

Our RT-PCR data showed that the mRNA expression levels of the NKCC1 transporters were
increased at PND 1 with a significant increase in the hippocampus of PND 1 of KO and KODBP mice. At PND 7, there was a decrease in the KO mice exposed to DBP in the cortex and the
hippocampus. At PND 60, this decrease was maintained in the KO mice exposed to DBP in the
cortex. Additionally, there was a significant decrease in the WT and KO mice exposed to DBP in
the hippocampus.

The increase in the expression of NKCC1 is critical from PND 1 right through to PND 7 as this
is the co-transporter that brings in chloride into the cell in order to maintain the chloride
electrochemical gradient that will keep GABA excitatory. The observation at PND 7 where DBP
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reduces the expression of NKCC1 drastically in the KO mice exposed to DBP could affect the
developmental shift from excitatory to inhibitory. The “excitatory” GABAergic system early in
development is crucial in setting up neuronal networks before the “inhibitory” GABAergic
system takes over. A delayed appearance in the “inhibitory” GABAergic system can lead to
improper neuronal network formation. Neurosteroids like estrogen have been reported to
augment the activity of NKCC1 and as a result, maintaining the chloride gradient conducive to
depolarizing when GABAA receptors are activated. In addition to this role, estradiol increases the
amount and activity of the NKCC1 (McCarthy, 2008). Disruption of neurosteroids can lead to a
quick decline in the expression of NKCC1 before being superseded by the transporter, KCC2.

In the KCC2 mRNA analysis, we observed a decrease in the mRNA expression of this protein in
the region of the hippocampus in the WT and KO DBP mice. Interestingly, there was a
significant decrease in the KO and the KO mice treated with DBP. Our findings in the KO mice
are concurrent with previous students conducted in our lab where KO mice at PND 1 expressed
significantly low levels of this co-transporter in the hippocampus (Xin dissertation – unpublished
data). At PND 7, there was a significant increase in the expression of KCC2 in the hippocampus
of KO mice; however this increase was suppressed by DBP. The suppression of KCC2 at PND 7
by DBP can delay the GABAergic system from shifting from excitatory to inhibitory. During
this critical period, the expression of NKCC1 should start to decline leading to an increase in the
expression of KCC2. The increase in KCC2 will extrudes chloride out of the cell, so that when
the GABAA receptors are activated, they will bring in chloride; resulting in an inhibitory
GABAergic system (McCarthy, 2008). A delay in this shift can be costly. The decrease in the
expression of KCC2 early in development has been observed and explained in a study conducted
by Galanopoulou (2005) who investigated neurons of the substantia nigra and the response to
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GABA agonists in rodents. This study reported findings that the down regulated co-transporter
KCC2 that extrudes chloride out of the cell maintained a depolarizing role of GABA A Rs. This
extended depolarizing action can be ineffective in establishing neuronal networks; however, if
the switch from NKCC1 to KCC2 is delayed for an extended period of time, neurotoxicity or a
series of seizures can occur (McCarthy 2008).

To conclude, the timed expression of these co-transporters is critical in establishing neuronal
networks by the GABAergic system. Although both the NKCC1 and KCC2 were decreased in
the WT and KO mice exposed to DBP at PND 60, the timely expression of these co-transporters
is critical. A significant delay in the expression of any of the two co-transporters can alter or
delay the GABA shift from excitatory to inhibitory. This delay that can be caused by DBP can
cause consequences resulting in improper neuronal network formation.

THE

EFFECTS

OF

GESTATION

EXPOSURE

OF

DBP

ON

NEURONAL

EXCITABILITY AND NEUROBEHAVIOR
DBP affects neuronal excitability later in development.

After confirmation that DBP reduced the expression of key proteins in neurosteroidogenesis,
GABAergic system and the co-transporters later in development, we hypothesized that the
reduction in the expression of these critical proteins will affect neuronal excitability. To further
confirm this hypothesis, we tested the threshold for seizure induction as an index for the potency
of the GABAergic system. We found that the offspring of DBP-injected mice had a significant
decrease in the threshold of limbic seizures as measured by reduced latency, reduced duration
and increased mortality rate in response to kainic acid injection (15mg/kg BW). We proceeded
by conducting an electrophysiological study to access whether we would produce similar
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findings using low levels of kainic acid injection (5 mg/kg BW). Our data showed that the in vivo
electrophysiological recordings from the motor cortex of DBP- administered mice experienced
higher frequency seizure activity when administered the low dose of kainic acid compared to the
WT controls. Furthermore, the KO-DBP mice experienced uncontrollable seizure activity
towards the end of the post-stimulation period. These finding confirmed that the GABAergic
system is critical later in development. A “compromised” GABAergic system can lead to less
inhibition and increased susceptibility to seizures. Furthermore, a decrease in the expression of
steroidogenic proteins that synthesize neurosteroids can alter the allosteric modulation of the
GABAA receptors.

DBP affects neurobehavior later in development

Collectively, molecular and electrophysiological studies indicated that the neurobehavior of mice
exposed to DBP would also be altered if the proteins that establish neuronal networks and
formation are affected. As normal behavior of mice is dependent on an “intact” GABAergic
system that is not compromised, we hypothesized that the down regulation of the steroidogenic
key proteins (P450scc and StAR), GABAergic proteins (GAD67, GABAARs), VSCCs and the
co-transporters (NKCC1 and KCC2) would affect how the mice behaved.

The OF and EPM demonstrated that the gestational exposure of DBP in the offspring mice at
PND 60 exhibited increase in locomotor activity and anxiety which is consistent with findings of
a compromised GABAergic system. In addition, these mice experienced heightened fearpotentiated freezing response and a significant decrease in learning as measured by the
acquisition and retention of a passive avoidance task. The neurobehavioral effects elicited by
prenatal exposure to this phthalate were consistent with altered inhibitory function in the brain of
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both WT and KO mice. The social interaction study showed that mice that were exposed to DBP
spent less time socializing with a novel mouse compared to the WT control. There was a
significant reduction observed in the KO mice that were exposed to DBP prenatally. This critical
observation was also noted in the KO mice (Xin – unpublished data). The Morris Water Maze
showed similar findings where mice exposed to DBP showed a deficit in performing a certain
task. The mice exposed to DBP travelled much longer distances to find the hidden platform;
therefore, the latency to find the platform was high compared to the WT control. These findings
were consistent with studies by Li et al., 2014 showing that DBP affects the estrogen receptor- β
(ER- β). Estrogen and its receptor play a significant role in the development of the CNS through
regulating a diverse array of intracellular signaling cascades. Decreased expression of ER- β
could affect hippocampal synaptic plasticity and memory (Belcher et al., 2001). Our Morris
Water Maze findings were also concurrent with Li and colleagues (2013) findings where they
reported that the latency to find the escape platform was increased in PND 22 male rats exposed
to perinatal DBP compared to the male rat controls. They indicated that DBP impaired the spatial
learning and memory of offspring rats. Finally, our analysis of the contextual fear task revealed
findings that WT mice learned to associate contextual cues with predictive foot shock without
issues in a linear progressive manner during the 4 trials. In contrast WT-DBP mice showed an
elevated fear response that remained ~ 75% higher throughout testing. KO and KO-DBP mice
had difficulty associating the information and exhibited hyperactivity (which reduced freezing)
across all trials. As the KO mice already exhibit a decrease in GABAARs, express a decrease in
the steroidogenic proteins P450scc and StAR that are responsible for synthesize the steroid
hormones that allosterically modulate GABAARs; it was a clear indication that the reduction in
these proteins could be contributing to this hyperactive phenotype.
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CONCLUSION

Collectively, our present findings revealed that gestational exposure of DBP significantly
decreases the expression of the key proteins P450scc and StAR in the steroidogenic pathway.
This disruption could induce neurotoxicity due to the link between neurosteroids like estradiol,
pregnanolone and the GABAergic system early in development. Critical supporting proteins that
contribute to the functioning of this system like the co-transporters, NKCC1 and KCC2 are also
affected by DBP. Additionally, the VSCCs, a critical protein channels that are also at the driving
force of neurogenesis are also compromised by DBP later in development. Although all the
mRNA levels that we examined in this system varied in the expression at PND 1 and 7, the
expression of mRNA and proteins in the presences of DBP were significantly decreased later in
development at PND 60. In addition to this decrease in mRNA and protein expression, we
observed an alteration in the behavior of these mice that was consistent with autism-like
behavioral symptoms. The neurobehavior of hyperactivity, reduction in social interaction,
memory and heightened fear potentiated freezing are behaviors similar to those observed in
autism like disorders.

These findings suggest that neurosteroids play a significant role in driving development with the
orchestrated synchrony of GABAARs, GAD67, L-type VSCCs and the co-transporters NKCC1
and KCC2. Gestational exposure to DBP affected the expression of these genes at various
developmental stages with resulting alterations in the behavior of the offspring. These
behavioral, molecular and biochemical alterations in response to DBP are suggestive that
environmental toxins may be responsible for the onset of autism-like behavior and may
contribute to the etiology of this syndrome.
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